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ABSTRACT OF THE DISSERTATION
Evaluating Racial and Geospatial Disparities and Contextual Factors in Triple-Negative
Breast Cancer among Women with Breast Cancer
by
Lia Cenni Barnar Scott
The objective of this study is to examine racial and geospatial disparities in triple-negative breast
cancer diagnosis. Breast cancer, in general, carries an enormous public health burden. Triplenegative breast cancer has greater morbidity and mortality, presenting approximately 9% of all
breast cancer diagnoses, in this study. This type of breast cancer has been significantly associated
with younger age, African American race, later stage diagnosis, lower socioeconomic status and
worse survival. The proposed study will be the first of its kind to use data from the United States
Cancer Statistics database which includes combined cancer incidence data from the Centers for
Disease Control and Prevention’s (CDC) National Program of Cancer Registries (NPCR) and the
Surveillance, Epidemiology, and End Results (SEER) Program covering 99% of the population
in comparison to 28% with SEER data alone. This study evaluates individual, social and physical
environmental factors associated with disparate rates of diagnosis. Predictors of interest include
person level-predictors (race, age, and stage of diagnosis), county-level predictors (residential
segregation, social capital and socioeconomic climate), and state-level predictors (breast cancer
screening mandates, state-level underinsured rates and state-specific restrictions on nurse
practitioner or physician assistant scope of practice). Descriptive epidemiologic analysis allowed
us to compare incidence of triple negative breast cancer across race and age groups at the
individual level. This study confirmed that Non-Hispanic black women consistently had
approximately twice the odds of diagnosis of triple negative breast cancer given breast cancer
diagnosis, when compared to Non-Hispanic white women. Younger age and late stage diagnosis
1
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also conferred higher odds. Exploratory spatial data analysis was used to create descriptive maps
and evaluate patterns of geospatial clustering and underlying community characteristics. This
study found distinct patterns of breast cancer and triple negative breast cancer rates at the county
level. It found 159 counties where breast cancer rates and triple negative breast cancer rates were
concurrently high and 97 counties where breast cancer rates were low, but triple negative breast
cancer rates were high. Spatial regression techniques demonstrated that residential segregation
was consistently associated with both breast and triple negative breast cancer rates. Isolation was
found to be detrimental while diversity was advantageous. Multilevel modeling allowed the
exploration of predictors of triple-negative breast cancer diagnosis at the individual level.
Consistently, race, age and late stage diagnosis conferred higher odds of diagnosis with triple
negative breast cancer, given breast cancer diagnosis. Residential segregation measures were
consistently associated, with isolation conferring higher odds and diversity conferring lower odds
of diagnosis. The results of these studies potentially inform policy at actionable geographic
levels and add valuable information to cancer health disparities research. Additionally, they
provide insight that there is still a need to explore what factors may be driving racial and
geospatial disparities in triple negative breast cancer in the United States.
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Chapter 1
Literature Review and Statement of Purpose
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Epidemiology of Triple-Negative Breast Cancer
Carcinoma of the breast, or breast cancer, is the most common type of noncutaneous
cancer among women. It is expected that there will be 63,960 in situ cases, 266,120 invasive
cases, and 40,920 deaths in women in 2018. The probability of developing invasive breast cancer
increases with age and is 12.4% or 1 in 8 for a lifetime. (Siegel, Miller, & Jemal, 2018). When
we examine the five leading causes of cancer death in 2015, among females, breast cancer is the
second only behind lung and bronchus. However, for age 20 to 59, it is the first leading cause of
cancer death (Siegel et al., 2018). Approximately 80% of breast cancers are invasive with up to
21 distinct histological subtypes and at least 4 different molecular subtypes (American Cancer
Society, 2017).
Numerous biologic subtypes of breast cancer demonstrate that it is a heterogeneous
disease (Carey et al., 2006). These subtypes are based on gene expression patterns that include
496 genes (Perou et al., 2000). There are five intrinsic subtypes recognized. Two estrogen
receptor (ER)-positive types include luminal A (ER+/progesterone receptor (PR)-positive and
human epidermal growth factor receptor 2(HER2)-negative) and luminal B (ER+/PR+/HER2+).
Three ER-negative types include ER-/PR-/HER2+, basal-like (ER-/PR-/HER2-/cytokeratin 5/6
(CK5/6) +), and unclassified ‘normal-like’ (negative for all markers) (Yang, Pfeiffer, et al., 2007;
Yang, Sherman, et al., 2007). These subtypes differ markedly in prognosis and therapeutic
targets (Sorlie et al., 2001). Luminal A tumors have the most favorable clinical features,
followed by luminal B (Yang et al., 2007). ER positive tumors respond to endocrine therapy such
as antiestrogen administration or ovarian suppression. HER2 positivity provides bases for
targeted therapy with monoclonal antibody against HER2 (Bauer et al., 2007) Basal-like tumors
have poor clinical features and survival, due to the negative ER and HER2 status. ER and PR
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negative tumors account for approximately 20% of breast cancers with known receptor status
and include the most clinically aggressive tumors (Yang et al., 2007). Triple negative breast
cancer (TNBC) accounts for approximately 12-15% of all breast cancer cases and approximately
75-90% are deemed basal-like (Dolle et al., 2009; American Cancer Society, 2017). TNBC is
associated with aggressive histology, poorer prognosis, shorter survival, and unresponsiveness to
usual hormone and HER2 immunotherapy (Bauer, Brown, Cress, Parise, & Caggiano, 2007).
This is important to note as basal-like tumors have a characteristic morphology that includes high
proliferative rate, central necrosis, and a pushing border (when the edge of the tumor appears to
be pushing into normal tissue) and have been associated with aggressive histology, unresponsive
to hormone therapy, poor prognosis, and BRCA-1 gene mutation (Dolle et al., 2009; Kreike et al.,
2007; Livasy et al., 2006; Foulkes et al., 2003; Perou et al., 2000; Sorlie et al., 2001; Sorlie et al.,
2003; Foulkes et al., 2010).
Triple negative breast cancers are more likely than any other breast cancer type to
metastasize to viscera, specifically the lungs and the brain (Foulkes et al., 2010). There is
approximately a 40% chance of first distant recurrence in the lungs for metastatic triple negative
breast cancer, while there is only a 20% chance for non-triple negative breast cancer (Foulkes et
al., 2010). A study conducted using the California cancer registry found that the triple negative
phenotype was statistically significantly associated with younger age, Non-Hispanic black
race/ethnicity, later stage diagnosis, lower SES and shortened survival (Bauer et al., 2007). NonHispanic black women also have statistically significant earlier age at diagnosis, higher
proportion of high grade tumors, and a higher proportion of triple-negative breast cancers
suggesting that breast cancer in Non-Hispanic black women is biologically different (Chu,
Lamar, & Freeman, 2003; Newman, 2005). These disparate outcomes and lack of knowledge of
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etiology of disease provide reason as to why research must shift focus from treatment to
identifying risk factors, albeit environmental or genetic, that exacerbate disparities in breast
cancer diagnosis to develop and implement more efficacious population-based prevention
strategies.
Individual Risk Factors
Race - Disparities between Non-Hispanic black and Non-Hispanic white women
Racial disparities exist within breast cancer diagnoses, particularly between non-Hispanic
white and non-Hispanic black populations. Incidence trends from 2005 to 2014 demonstrate that
invasive breast cancer rates were stable for non-Hispanic white women and increased slightly for
non-Hispanic black women. Over the 10-year span, invasive breast cancer rates for NonHispanic black women increased approximately 3%. Overall breast cancer mortality rates have
declined since 1989. Mortality peaked in 1989 at 33.2 deaths per 100,000 and declined 39% to
20.3 deaths per 100,000 in 2015. This decline has been attributed to early detection and
screening. The annual percent decline from 2006 to 2015 was larger for non-Hispanic white
women compared to non-Hispanic black women, 1.8% versus 1.5%, respectively (Siegel et al.,
2018).
According to SEER data from 18 registries, the lifetime relative risk of all breast cancers
from 2013-2015 for Non-Hispanic black women compared to Non-Hispanic white women is
0.90, indicating Non-Hispanic black women are at lower risk for diagnosis, yet the lifetime
relative risk for dying of breast cancer is 1.22. When Non-Hispanic black women are diagnosed
with breast cancer, there are 22% more likely to die from the disease. Age-adjusted incidence
rates from 2011- 2015 were 128.6 per 100,000 for non-Hispanic white women and 126.9 per
100,000 for non-Hispanic black women. The age-adjusted mortality rates from breast cancer in
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2011-2015 for Non-Hispanic black women was 28.7 per 100,000 and 20.3 deaths per 100,000 for
Non-Hispanic white women (Noone et al., 2018). When examining cases from 2008 to 2014,
Non-Hispanic white women had a higher percentage of localized disease as compared to NonHispanic black women (63% vs 54%), yet the 5-year relative survival rate for Non-Hispanic
black women was lower in terms of localized (99.1% vs 95.4%), regional (86.4% vs 76.6%), and
distant stages (28.1% vs.19.7%) (Noone et al., 2018). Survival in Non-Hispanic black women
may be worse due to a higher frequency of adverse histologic features (Bauer et al., 2007).
Incidence data are from the 18 registries, while mortality data are for the entire United States.
Lifetime Exposure to Estrogen
Besides race, research has established multiple individual risk factors associated with
breast cancer diagnoses, although the complete etiology of the disease remains unknown.
Lifetime exposure to estrogen has been linked to increased risk for breast cancer (Loeffler &
Hart, 2014). These factors include early menarche, late menopause, no or fewer children, and
receiving exogenous estrogen (Loeffler & Hart, 2014).). In addition, women who had children
but did not breastfeed are at increased risk compared to those who breastfed (Loeffler & Hart,
2014). High levels of circulating estrogens and androgens have been associated with increased
risk of breast cancer in premenopausal women (Key et al., 2013). Parity also plays a role. Having
a first child before 35 and a greater number of children is associated with decreased risk for
hormone receptor positive breast cancers (Lambertini et al., 2016). On the contrary, there is an
increase in hormone receptor negative breast cancer risk that last about 10 years post full-term
pregnancy, particularly among women who are older at birth (Albrektsen, Heuch, Hansen, &
Kvåle, 2005; Schedin, 2006). Breastfeeding also slightly reduces overall risk of breast cancer if
done for at least a year (Faupel-Badger et al., 2012). The risk of breast cancer is reduced by 4%
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for every 12 months of breastfeeding (Collaborative Group on Hormonal Factors in Breast
Cancer, 2002). This may be due to the inhibition of menstruation when breastfeeding, thus
reducing lifetime number of menstrual cycles, or the structural changes that occur in the breast
following lactation and weaning (Britt, Ashworth, & Smalley, 2007; Faupel-Badger et al., 2012).
This effect was found to be stronger among triple-negative cases (Faupel-Badger et al., 2012;
Islami et al., 2015; Sisti et al., 2016).
Family History
Women with a family history of breast cancer, especially in a first-degree relative have
an increased risk of breast cancer diagnosis. When we compare them to women without a family
history, their risk of diagnosis is twice as high when there is only one affected first degree female
relative, and almost 4 times as high when there are multiple first-degree female relatives with
breast cancer (Collaborative Group on Hormonal Factors in Breast Cancer, 2001). Additionally,
a family history of ovarian cancer is also associated with higher risk of breast cancer diagnosis
(American Cancer Society, 2017). Women who have been diagnosed with breast cancer have a
small increased risk of developing a new cancer in the opposite breast (Nichols, De González,
Lacey Jr, Rosenberg, & Anderson, 2011). Ductal carcinoma in situ (DCIS) and Lobular
Carcinomas in situ (LCIS) are both potential precursors for invasive breast cancer. Women with
a history of DCIS are 10 times more likely to be diagnosed with an invasive breast cancer and
women with LCIS are 7 to 12 times more likely to develop invasive breast cancer compared to
women with either (King et al., 2015; Lopez‐Garcia, Geyer, Lacroix‐Triki, Marchió, & Reis‐
Filho, 2010; Morrow, Schnitt, & Norton, 2015).
Genetic Predisposition
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The most indicative of these risk factors is the mutation of the BRCA genes. BRCA genes
are tumor suppression genes that repair damaged DNA and prevent cell division in damaged
cells. A mutation in either BRCA-1 or BRCA-2 increases the risk of breast cancer from 12% up to
70% (Kuchenbaecker et al., 2017). These mutations occur at a rate of less than 1% in the general
population but occur slightly more often in certain ethnic or geographically isolated groups
(Gabai-Kapara et al., 2014). Another gene that works with BRCA-2, PALB-2, appears to confer
risk that may be as high as BRCA-2 mutations (Antoniou et al., 2014). Multiple research avenues
are being explored to determine what oncogenes or tumor suppressor genes play a role in the
various subtypes of breast cancer (Li et al., 2015; McLean et al., 2015; Plíšková, Vondráček,
Vojtěšek, Kozubík, & Machala, 2004). There are no known recurring breast cancer gene
mutations that have an increased frequency in non-Hispanic black women (Chen et al., 1994;
Cross, Harris, & Recht, 2002; Gao, Neuhausen, Cummings, Luce, & Olopade, 1997; Newman et
al., 1998; Shen et al., 2000). Additionally, not much is known about the interaction of genes and
environmental factors that may be different between non-Hispanic black and non-Hispanic white
women (Cross et al., 2002).
Height
Height has also been associated with increased breast cancer risk (Green et al., 2011; van
den Brandt et al., 2000). A study found that in a European sample, height was an independent
risk factor for breast cancer among postmenopausal women, but the relationship was unclear
among premenopausal women (van den Brandt et al., 2000). Increased height was associated
with increased risk of cancer and cancer death in another European study (Wirén et al., 2014).
Height may be reflective of differences in early growth or hormonal factors.
Obesity
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Obesity plays a different role in breast cancer risk when we compare pre- and postmenopausal women. In a meta-analysis study of premenopausal women, breast cancer risk was
1% lower in overweight women and 26% lower in obese women compared to women of normal
weight (Nelson et al., 2012). However, this may be limited to hormone receptor positive tumors.
The postmenopausal risk of breast cancer is 1.5 times higher in overweight women and 2 times
higher in obese women (La Vecchia, Giordano, Hortobagyi, & Chabner, 2011). Obesity is also a
risk factor for type II diabetes which is linked to increases risk of postmenopausal breast cancer
(16% increase) (Boyle et al., 2012; Maskarinec et al., 2017; Tsilidis, Kasimis, Lopez, Ntzani, &
Ioannidis, 2015). Women who exercise regularly had 10-20% lower risk of breast cancer
compared to women who are inactive (Pizot et al., 2016). The reduction is greater with
increasing amounts of exercise and vigorous activity, but even less vigorous physical activity,
such as walking, is beneficial (Hildebrand, Gapstur, Campbell, Gaudet, & Patel, 2013). This may
be because of the effect of physical activity on inflammation, hormones, and energy balance
(Neilson, Friedenreich, Brockton, & Millikan, 2009; Pizot et al., 2016).
Determination of Social Environmental Risk Factors
The identification of factors that create and exacerbate these disparities would be an ideal
outcome of this and future cancer epidemiology studies. Biological risk factors have been
identified and are consistently validated, yet disparities still exist. Dating back to 1991,
socioeconomic status (SES) has been studied as a factor in cancer incidence. A study examining
the association between census tract level income and educational levels as proxies for
socioeconomic status and cancer incidence at all sites combined found that the disproportionate
distribution of the non-Hispanic black population at lower socioeconomic levels accounts for
much of the excess burden among this population (Baquet, Horm, Gibbs, & Greenwald, 1991).
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SES variables are not collected with patient characteristics in cancer registries. Thus, it is not
surprising that few studies have explored the role of social environmental risk factors in triple
negative breast cancer diagnosis, specifically (Chu, Henderson, Ampil, & Li, 2012; Dolle et al.,
2009). Collection of additional social environmental risk factors that vary among women can
inform both policy and clinical practice. Lacking such person-specific SES data, this study aims
to illuminate the role that residential segregation, socioeconomic conditions and other contextual
factors in the counties where women live may play in the diagnosis of TNBC. This study looks at
the following factors from an ecological standpoint, rather than compositional.
Residential Segregation
Residential segregation adversely impacts the health of non-Hispanic black persons
(Collins, 1999; Collins & Williams, 1999). Segregation promulgates negative social
environments as highly segregated cities often experience higher levels of violent and property
crimes (Kramer & Hogue, 2009; Peterson & Krivo, 1993; Velez, Krivo, & Peterson, 2003).
Residential segregation impacts access to health-relevant sources. Even after controlling for risk
factors, segregation may have a statistically significant effect on health outcomes because of the
way it shapes contact patterns and social networks (Acevedo-Garcia, 2000; Acevedo-Garcia,
Lochner, Osypuk, & Subramanian, 2003).
There has research conducted using SEER registry data and a sample of 395,671 US-born
non-Hispanic black and non-Hispanic white women that found that Jim Crow birthplace was
associated with increased odds of estrogen receptor negative breast cancer among non-Hispanic
black women with the strongest effect for women born before 1965 (Krieger, Jahn and
Waterman, 2017). In terms of breast cancer care, Haas and colleagues (2008) found that nonHispanic black segregation was a mediator of the Black/White disparity in breast cancer care.
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They also found that both non-Hispanic black and non-Hispanic white women who lived in areas
of greater non-Hispanic black segregation were less likely to receive adequate breast cancer care.
Socioeconomic Status
Socioeconomic position has been linked to breast cancer incidence. Studies show that this
construct is positively related to breast cancer incidence overall, but the association varies by
race or ethnicity (Bigby & Holmes, 2005; Yost, Perkins, Cohen, Morris, & Wright, 2001).
Research demonstrates that the United States is the most unequal in terms of wealth distribution
among all developed countries. The top 1 percent of households own 38 to 47 percent of all
wealth (Keister & Moller, 2000; Wolff, 1996, 1998). The Gini coefficient is the most commonly
used indicator of income inequality, and its use here allows for comparisons with other income
inequality studies (Jones-Smith, Gordon-Larsen, Siddiqi, & Popkin, 2011; Nowatzki, 2012). The
association between income inequality and mortality has also been established at cross-country
and national levels (Chetty et al., 2016; Kaplan, Pamuk, Lynch, Cohen, & Balfour, 1996;
McIsaac & Wilkinson, 1997).
Education is often considered a social determinant of health under the umbrella of
socioeconomic status. One study found that having low self-reported education was associated
with subtypes of estrogen receptor negative and progesterone receptor negative breast cancers
(Trivers et al., 2009). Additionally, women in their study with triple negative tumors were more
often of lower SES. Low-income women have mammography screening rates that are lower than
higher income women (Peek & Han, 2004). Additionally, women with lower education have
lower mammography screening rates (Kerner et al., 2001). Women in low-income areas are more
likely to present with late stage disease and socioeconomic position has also been association
with treatment (Schwartz, Crossley-May, Vigneau, Brown, & Banerjee, 2003).
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Low socioeconomic status has been linked to decreased rates of screening, greater
probability for late-stage diagnosis, receipt on inadequate and disparate treatment and higher
mortality from breast cancer (Bigby & Holmes, 2005; Gerend & Pai, 2008). Regardless of race,
poverty is associated with poorer breast cancer outcomes (Gerend & Pai, 2008). Socioeconomic
status is often linked to access to care as they often go hand-in-hand. Those with lower
socioeconomic status are less likely to have employment stability that provides adequate
insurance for care. Additionally, studies have found that the non-Hispanic black population is
twice as likely to be uninsured and depend on public insurance compared to the non-Hispanic
white population (Thomasson, 2006). Uninsured and underinsured women are less likely to
undergo screening, more likely to receive a late stage diagnosis and less likely to survive
(Bradley, Given, & Roberts, 2002; Buseman, Byers, Finch, & Jacobellis, 2002; Gerend & Pai,
2008; Gordon, Rundall, & Parker, 1998; Hsia et al., 2000; Roetzheim et al., 1999). Women who
reside in disadvantaged communities may be required to travel longer distances with longer wait
times to utilize screening and treatment facilities. These factors can cause a major hindrance in
regular physician visits (Mandelblatt, Andrews, Kao, Wallace, & Kerner, 2010; Mandelblatt,
Andrews, Kerner, Zauber, & Burnett, 1991; Mandelblatt, Yabroff, & Kerner, 1999; Vernon,
Vogel, Halabi, & Bondy, 1993).
Higher socioeconomic status confers a higher risk of breast cancer diagnosis, while lower
socioeconomic status confers higher risk of triple negative breast cancer diagnosis. In terms of
triple negative diagnosis, this type occurs more frequently in younger women and in nonHispanic black women (Bauer et al., 2007; Dent et al., 2007; Haffty et al., 2006; Harris et al.,
2006; Morris et al., 2007; Tischkowitz et al., 2007). Socioeconomic status has been examined as
a factor in breast cancer incidence and the National Action Plan on Breast Cancer Workshop
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recommended that it be an integral part of research in breast cancer etiology, since this variable
is associated with many other factors in an individual’s life (Dayal, Power, & Chiu, 1982;
Gordon, 2003; Krieger, 1990; Moormeier, 1996). Even after these factors have been taken into
consideration, racial and geospatial disparities still exist. It is important to explore how these
individual and social factors are associated with breast cancer diagnosis, broken down by
subtype.
Gaps in the literature and this study’s contributions
Research has primarily been focused on identifying individual risk factors with small
sample sizes. There appears to be a consensus that age and race play significant roles in the
diagnosis of TNBC, yet with the knowledge we have, disparities still persist. This dissertation
aims to validate these small study findings, as it is the first to use a near complete population
dataset, the United States Cancer Statistics database (USCS). It takes a step back and evaluates
how the social environment may play some role in TNBC diagnosis. Additionally, it allows us to
evaluate modifiable risk factors in TNBC, thus is more useful in addressing the disparities
between Non-Hispanic black and Non-Hispanic white women. When analyses are done at the
local geopolitical level, such as the county, we are able draw conclusions and in turn develop and
implement prevention strategies that are more conducive to these well-defined geographic areas.
With the recent, wider availability of the USCS database, more studies are beginning to
examine societal and community contributors to breast cancer diagnoses. Some of these have
used a spatial analytic perspective (Kuo et al., 2011; Mobley et al., 2017; Mobley & Kuo, 2015a,
2015b; Mobley, Kuo, & Andrews, 2008; Mobley, Kuo, Urato, et al., 2012; Mobley, Kuo,
Watson, et al., 2012; Mobley, Scott, Rutherford, & Kuo; Mobley et al., 2017). The few studies
that have examined community characteristics have been mainly descriptive (Beyer & Rushton,
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2009; Roche, Skinner, & Weinstein, 2002). Race and residential segregation as representatives
for social support has been of particular focus when examining breast cancer disparities (Bradley
et al., 2002; Haas et al., 2008a, 2008b; Kuo et al., 2011; Mobley et al., 2017; Warner & Gomez,
2010). The use of the expansive Spatial Impact Factor (SIF) dataset along with other free, publicuse population health data allows for more in depth identification and evaluation of additional
potential contributors. The SIF database contains a time series of cross sections reflecting
multiple community level variables including but not limited to residential segregation, poverty,
income inequality, food security and urbanicity. The database is supplemented by additional
data from the Area Health Resource File and Pennsylvania State University (Bureau of Health
Workforce, 2017; Rupasingha, Goetz, & Freshwater, 2006). These data are drawn primarily from
the U.S. Census Bureau data.
Few descriptive studies have explored individual and community (county and state) level
contributors to breast cancer outcomes, using multilevel analysis or spatial regression. This study
will update previous SEER registry publications by expanding the geographic scope of these
studies. The use of the comprehensive USCS database allows for an unprecedented exploration
of this health outcome. Additionally, this study will employ statistical methods that allow for
inference to accompany the more descriptive studies. Geospatial analysis and statistical and
spatial modeling will provide insight to better inform policy and design prevention strategies,
particularly due to the inclusion of social environmental risk factors.
Few previous studies have examined social environmental predictors in triple-negative
breast cancer. Using the entire USCS registry database would provide enough of these rare
cancer cases and a broad spectrum of geospatial heterogeneity, yielding the best possible study
design for these disparities. Only recently have USCS database studies been conducted
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concerning population cancer outcomes associated with state-level health policy factors (Mobley
& Kuo, 2015a, 2015b). Previous studies have also found that constructs representative of social
support can be influential on both breast cancer screening and stage of diagnosis models (Kuo,
Mobley, & Anselin, 2011; Mobley, Kuo, Scott, Rutherford, & Bose, 2017; Mobley, Kuo, Urato,
et al., 2012; Mobley, Kuo, Watson, & Gordon Brown, 2012). These studies provide limited
evidence that the environment does impact cancer stage at diagnosis. The use of the USCS
dataset (U.S. Cancer Statistics Working Group, 2017) allows for an expansion of these studies to
fully inform healthcare policy and may potentially reveal contributory factors to typology and
staging at diagnosis.
Methodological Approaches
This study utilizes a variety of methodological approaches with a comprehensive dataset
to address the different aspects of TNBC incidence. The USCS dataset provides the best source
of information on population-based cancer incidence for the nation (Henley et al, 2010). Data
must meet six USCS publication criteria: 1) case ascertainment is ≥90% complete, 2) ≤5% of
cases are ascertained solely on the basis of a death certificate, 3) ≤3% of cases are missing
information on sex, 4) ≤3% of cases are missing information on age, 5) ≤5% of cases are missing
information on race, and 6) ≥97% of the registry's records passed a set of single-field and interfield computerized edits that test the validity and logic of data components (Henley et al, 2010).
These registries cover approximately 99% of the U.S. population, including 96% of the U.S.
non-Hispanic white population, 99% of the U.S. non-Hispanic black population, 89% of the U.S.
AI/AN population, 98% of the U.S. API population, and 96% of the U.S. Hispanic population
(Henley et al., 2010; U.S. Cancer Statistics Working Group, 2017). This is substantially more
comprehensive compared to the SEER Program with covers approximately 28 percent of the
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U.S. population, including 25 percent of non-Hispanic whites, 26 percent of African Americans,
38 percent of Hispanics, 44 percent of American Indians and Alaska Natives, 50 percent of
Asians, and 67 percent of Hawaiian/Pacific Islanders (SEER, 2018).
The first study aims to validate the findings of smaller, more localized studies.
Traditional epidemiologic analysis is used in this study, such as descriptive statistics, basic
inferential statistics and logistic regression. Using only the individual level data, we can
determine the odds of diagnosis with TNBC based on race, age and stage of diagnosis for women
with breast cancer. This is the first study of its kind to use national data in the exploration of
differences in person-level factors. However, the use of these methods can often confound race
and place.
The second study aims to supplement the descriptive analysis by evaluating descriptive
geospatial patterns of disease at the county-level. Spatial analysis is the primary methodological
toolkit used in the proposed study. A variety of geographic information system and spatial
analytic approaches have been utilized in previous analyses in the literature. These methods often
include simple GIS and mapping, Bayesian image analysis, SaTScan, and generalized linear
modeling (Goovaerts, 2010; Gumpertz, Pickle, Miller, & Bell, 2006; MacKinnon et al., 2007;
McElroy, Remington, Gangnon, Hariharan, & Andersen, 2006). This study will employ the use
exploratory and confirmatory spatial data analysis through descriptive mapping, the Local
Moran’s I or LISA statistic and spatial regression. This study focuses on underlying county-level
factors and how they vary across extremes in the pattern and is limited to ecological
interpretation due to the use of contextual data. The use of geospatial analysis allows us to
pinpoint where problems and disparities exist, thus we can better develop prevention programs as
well as provide informed, culturally competent treatment. There is great potential to reveal new
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information or confirm existing information on disparities within this outcome due to the various
spatial analytic methodologies and datasets proposed for this study.
The third study moves further into explaining how person-, county- and state-level
factors can explain TNBC diagnosis at the individual level. To address the fallacies of singlelevel research, it is important to consider contexts and multi-level phenomena when conducting
population health research (Oakes, 2009). Additionally, the multi-level approach allows us to
address spatial heterogeneity found in the previous studies from this dissertation, and causality
cannot be inferred from this study. Rather, this study aims to inform the literature on potential
contextual contributors to disparate rates and explore if disparities persist when controlled for.
The socioecological model acknowledges the importance of context and this study aims to
elucidate the specific role residential segregation and socioeconomic conditions play in diagnosis
(Gomez et al, 2015). Multi-level studies can be used to inform multi-level interventions. We
consider the socioecological model of the cancer continuum in this study (Figure 1).
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Figure 1. Socioecological model on the Cancer Continuum (Gomez et al., 2015)

Overall, the proposed study intends to fill several significant gaps in the literature by
conducting population-based secondary analyses that will evaluate racial, ethnic and geospatial
disparities in triple negative breast cancer. Current evidence provides reasons regarding why
research must shift focus from treatment to prevention through the identification of risk factors,
albeit environmental or genetic, that exacerbate disparities in breast cancer diagnosis to create
and implement more efficacious population-based prevention strategies. The study will use data
from United States Cancer Statistics (USCS) database, which includes combined cancer
incidence data from the Center for Disease Control and Prevention’s (CDC) National Program of
Cancer Registries (NPCR) and the SEER Program. Each data point in the study is considered a
case and we expect over 1 million observations in the time period of 2010 to 2014. Case-only
studies are useful in understanding the heterogeneity among the cases (Begg & Zhang, 1994;
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Trivers et al., 2009). This data covers 99% of the population during 2009-2013 and 92% during
1999-2013 (Richardson, Henley, Miller, Massetti, & Thomas, 2016).
No previous studies have examined disparities and their predictors in triple-negative
breast cancer or other aggressive, invasive cancer typologies using the entire USCS database.
Both demographic and geographic disparities exist, and these are different constructs that must
both be elucidated to inform disparities reduction descriptive analysis is the first national
analysis of population-based cancer incidence.
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Statement of Purpose
The purpose of this study is to evaluate racial and geographic disparities in triplenegative breast cancer (TNBC) diagnoses by race or ethnicity both within regions and across
regions. The primary outcome of interest is TNBC, breast cancer with immuno-histochemical
suppression of estrogen-receptor (ER), progesterone receptor (PR), and human epidermal growth
factor receptor 2 (HER2), at first diagnosis. Previous studies have examined disparities but not
on the population scale, often focusing on the individual level. Studies also fail to examine multilevel effects, which is what this study will examine. This study will evaluate spatial clustering of
TNBC at the county-level and examine environmental predictors of triple-negative breast cancer
status using NPCR data available for 45 states, combined with SEER data for the remaining 5
states. This study uses a subset of the data to include states that allow the use of county-level
incidence data, have available contextual data, as well as states that code for TNBC. This reduces
the state sample size to 39 states. Five states do not provide county-level breast cancer data –
Illinois, Kansas, Michigan, Minnesota and Missouri – and four do not code for triple negative
data – Connecticut, Iowa, New Mexico, and Utah. Alaska and Hawaii are excluded from analysis
due to missing contextual data. This study aims to account for personal, social and environmental
factors such as age, race, socioeconomic status, residential segregation and other neighborhood
characteristics and their impacts on TNBC outcomes.
The overarching goal of this study is to advance the field of population-based research in
breast cancer disparities through innovative statistical techniques. The objective of this study is
to address racial and geospatial disparities in triple-negative breast cancer diagnosis and to
examine potential predictors of diagnosis. Breast cancer, in general, carries an enormous public
health burden and triple-negative breast cancer accounts for 15% of all breast cancer diagnoses.
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Morbidity and mortality burdens are higher with this type of breast cancer and diagnosis has
been significantly associated with younger age, African American race, later stage diagnosis,
lower socioeconomic status and shortened survival. The proposed study will be the first of its
kind to use data from the United States Cancer Statistics database which includes combined
cancer incidence data from the Center for Disease Control and Prevention’s (CDC) National
Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results
(SEER) Program covering 99% of the population in comparison to 28% with SEER data alone.
This study will focus on racial disparities between Non-Hispanic black and Non-Hispanic white
women and geospatial disparities across the contiguous United States. It will evaluate individual,
social and physical environmental factors that contribute to disparate rates of diagnosis and
survival. Predictors of interest include, but are not limited to, person level-predictors – race, age,
and stage of diagnosis, county-level predictors – residential segregation, social capital and
socioeconomic climate, and state-level predictors – breast cancer screening rates, state-specific
restrictions on Nurse Practitioner or Physician Assistant scope of practice, and underinsurance or
self-insurance policies. Descriptive epidemiologic analysis will allow us to compare incidence of
triple negative breast cancer across race and age groups at multiple geographic levels.
Exploratory and confirmatory spatial data analysis will be used to create descriptive maps and
evaluate patterns of geospatial clustering and underlying community characteristics. Multilevel
modeling with latent variables will allow us to explore predictors of triple-negative breast cancer
diagnosis and survival. Results will robustly answer the question of both ‘why?’ and ‘where?’
thus potentially informing policy at actionable geographic levels and adding valuable
information to cancer health disparities research as a whole.
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We expect to find evidence of racial and geospatial disparities in TNBC. Additionally,
we expect statistical evidence of positive spatial autocorrelation of TNBC rates and that clusters
will have distinct community characteristics. Finally, we expect that the use of multi-level and
spatial analytic methods will better elucidate the various predictors and pathways of TNBC
outcomes and perhaps reveal specific geographic areas in greatest need of prevention or
intervention. The usual challenge in tackling this type of analysis is data limitation; however, we
largely overcome that by using the USCS database which covers 99% of the cancer population.
Identifying information will be protected due to the secure nature of the Research Data Center
and work conducted there, and the de-identification of datasets. Future work will expand upon
this spatial analytic research foundation to examine other types of breast or other cancers
demonstrate disparate rates, such as colorectal, cervical and prostate cancer.
The use of spatial analysis in a variety of methodologies allows us to robustly answer the
questions of ‘Why?’ and ‘Where?’ these cancer diagnoses are occurring. State and county level
characteristics will be used to model the spatial heterogeneity of TNBC diagnoses. Mixed
modeling allows us to examine multi-level variable predictors and influence on this particular
type of cancer diagnoses. There is no literature comparable and the proposed study will help fill
several significant gaps in the literature. This data-intensive, information-rich research strategy
is the future of applied population health research.
Study 1. Descriptive Analysis of Black/White Disparities in Triple Negative Breast Cancer for
the US – A Population Based Study from the USCS database
Triple negative breast cancer (TNBC) accounts for approximately 15% of all breast
cancer cases, and is associated with aggressive histology, poorer prognosis, shorter survival, and
unresponsiveness to usual hormone therapy (Bauer et al., 2007). A study conducted using the
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California cancer registry found that the triple negative phenotype was statistically significantly
associated with younger age, African American race/ethnicity, later stage diagnosis, lower SES
and shortened survival (Field et al., 2012; Field et al., 2005). Non-Hispanic black women also
have a significantly earlier age at diagnosis, high grade tumors, and a higher proportion of triplenegative breast cancers (Chu et al., 2003; Newman, 2005). The focus on TNBC is crucial as
there is a lack of therapeutic options for this specific typology. Thus, if one group is
disproportionately affected, the results can be devastating. No studies have examined racial
disparities across the US with the USCS database, as few have looked beyond the scope of one
state.
The research questions of interest are: Are the underlying distributions of age, race and
stage at diagnosis different for women with TNBC compared to women with all other types of
breast cancer? Do the odds of TNBC diagnosis among women with breast cancer differ by race,
age or stage at diagnosis, at the individual level? The research hypotheses are as follows: NonHispanic black women will have higher odds of TNBC diagnosis than their non-Hispanic white
counterparts in nationally aggregated data analysis. Younger women will have higher odds of
TNBC diagnosis and those diagnosed at late stage will have higher odds of TNBC diagnosis.
A descriptive epidemiologic study of the population dataset will be conducted to
determine whether there are non-Hispanic black-non-Hispanic white disparities between cases
with BC, and subcases with TNBC diagnoses. The unit of analysis is the individual. Proportions
and confidence intervals will be calculated and tested, using Chi-Square tests of independence to
detect differences in distributions of age groups and race. T tests will be used to detect
differences in average age. Bivariate and multivariate logistic regression analyses will be
performed to calculate odds ratios and confidence intervals comparing non-Hispanic black and
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non-Hispanic white differences, age group differences, and stage differences in diagnosis across
states of triple-negative diagnosis among breast cancer cases. This approach is similar to the
Bauer and colleagues (2007) California registry study.
Study 2. Examination of Geospatial Patterns in Triple-Negative Breast Cancer and Factors
across the United States
Geographic disparities in breast cancer and its late-stage diagnosis have been established
in the literature for several years (Henley, King, German, Richardson, & Plescia, 2010; Kerner,
Andrews, Zauber, & Struening, 1988; Siegel et al., 2018) Kerner and colleagues (1988) called
for the use of spatial analysis to inform prevention strategy and policy implementation. Since
then, a few studies have utilized spatial analysis in the evaluation of breast cancer outcomes
overall, and none have evaluated the TNBC typology (Sheehan et al., 2004; Wang, McLafferty,
Escamilla, & Luo, 2008; Wang, Burau, Fang, Wang, & Du, 2008). Additionally, no such studies
focused on the United States have utilized Anselin’s Local Moran’s I (LISA) statistics in the
analysis (Anselin, 1995). While other methods look for epicenters in a global pattern, the LISA
methodology accounts for local spatial instabilities in overall patterns of global spatial
association. This methodology is considered more reliable for inference in both the absence and
presence of spatial autocorrelation, allowing for the identification of concentrations of both high
and low values, and spatial outliers. Examining the spatial distribution of this aggressive triplenegative subtype at the county level provides insight at policy-actionable geographic levels. Use
of the comprehensive USCS database provides population-based results that are completely
generalizable. The proposed study seeks to fill several methodological and data-based gaps in the
literature.
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The research questions are as follows: Is there evidence of geospatial disparities in both
breast cancer and triple negative breast cancer diagnosis across the United States? Do these
clusters coincide? Can residential segregation and socioeconomic conditions predict triplenegative diagnosis? The research hypotheses are: There will be evidence of observed spatial
patterns (clustering) of higher-than-average and lower-than-average TNBC rates across the
United States. TNBC county rates will be associated with indicators of community disadvantage.
Presuming the presence of spatial clusters will lead to efforts to determine socio-ecological and
environmental characteristics associated with observed spatial patterns (e.g. socioeconomic
conditions and residential segregation).
Descriptive maps will be generated to demonstrate the distribution of TNBC across the
United States. The unit of analysis is the county. Spatial clustering is expected when examining
geospatial disparities. The first step is to determine the degree of global clustering using the
Global Moran’s I statistic. The null hypothesis states that the attribute (i.e., TNBC rates) is
randomly distributed among features (i.e., counties) in the study area – the contiguous United
States. The larger the Moran’s I statistic, the greater the local area variation observed in the
disease rates. A rejection of the hypothesis of spatial randomness with the Moran’s test
predicates use of the Local-Indicators of Spatial Analysis (LISA) test for identification of local
clusters. Positive spatial autocorrelation in TNBC rates among counties is represented by both
high-high and low-low clusters, while negative spatial autocorrelation is represented by high-low
and low-high clusters
Community characteristics will be represented using data from the Spatial Impact Factor
Database. The database is supplemented by additional data from the Area Health Resource File
and Pennsylvania State University (Bureau of Health Workforce, 2017; Rupasingha, Goetz, &
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Freshwater, 2006). This portion of the study will examine how one’s social environment may
correlate with rates of breast and triple negative breast cancer. Spatial regression techniques will
be employed to evaluate the association between county level social environment factors and
aggregate triple negative breast cancer rates.
Study 3. Multi-level Analysis of Person-, County- and State-Level Contributors to TripleNegative Breast Cancer Diagnosis among Women in the United States
The use of the mixed models is a novel approach to ecological-type regressions that
investigate risk factors (e.g. socioeconomic conditions, residential segregation, social capital,
housing adequacy from a health standpoint, access to primary care healthcare providers, and
state insurance mandates) related to breast cancer outcomes (Liu, Wall, & Hodges, 2005). This
could provide greater insights and explain substantially more of the variation in the observed
outcome. Multilevel modeling will be employed to explain the variation in TNBC diagnosis at
the individual level using person, county and state level predictors (e.g. socioeconomic
conditions, residential segregation, access to primary care healthcare providers, and state
insurance mandates). The aggregate level variables will include the community characteristics
such as socioeconomic conditions, residential segregation and social capital, and state-level
characteristics such as breast cancer screening mandates, and implementation of
Medicare/Medicaid expansion or state-specific restrictions on Nurse Practitioner or Physician
Assistant scope of practice. With this enhanced knowledge and effective dissemination and
translation of it, policies and interventions can be designed and targeted to address the barriers
and gaps that contribute to the observed TNBC outcomes. Model building for multilevel
analysis will allow us to explore how these predictors contribute to diagnosis of TNBC among
BC patients.
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The research questions are as follows: What is the predicted probability of triple negative
breast cancer diagnosis, given breast cancer diagnosis, among females in an average county in
the United States? What community variables are strong predictors of triple negative breast
cancer diagnosis among breast cancer cases? When we control for patient, county and state
characteristics, what is the relationship between patient race and odds of TNBC diagnosis, given
breast cancer diagnosis? The research hypotheses are: TNBC diagnosis will vary for females
across counties and counties within states and will be associated with several factors reflecting
community disadvantage. We anticipate that the odds of triple negative breast cancer diagnosis
will remain higher for Non-Hispanic black women compared to Non-Hispanic white women,
even when controlling for county and state level characteristics. Multilevel analysis will explain
the variation in diagnosis within and between racial groups using person, county and state level
predictors.
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Abstract
Triple negative breast cancer has been associated with a more aggressive histology,
poorer prognosis and nonresponsiveness to hormone therapy. Due to the lack of therapeutic
options for this cancer type, it is imperative that cancer research identify factors that drive
disparities and focus on prevention. This study expands upon the literature by examining the
outcome in population-setting rather than a sample, which can validate previous findings, by
capturing the majority of the population. Using the United States Cancer Statistics database, we
identified 1,151,724 cases of breast cancer from 2010-2014, with the triple negative phenotype
accounting for approximately 8.4% of all cases. The underlying distribution of age, race, and
stage were statistically significantly different when we compared triple negative breast cancer
cases to all other breast cancer cases. Unadjusted and adjusted logistic regression results found
that Non-Hispanic black and Hispanic women had higher odds of diagnosis when compared to
non-Hispanic white women, with non-Hispanic black women having over twice the odds of
diagnosis. Additionally, those less than 50 years old had higher odds of diagnosis while those
over 64 had lower odds, compared to age 50 to 64. Women younger than 40 had the highest
odds of diagnosis, as compared to the referent group, with an odds ratio of approximately 1.8.
Diagnosis at stage III and beyond conferred higher odds of diagnosis of triple-negative breast
cancer. In adjusted analyses, these disparities persisted. A subset analysis was conducted on just
non-Hispanic black and non-Hispanic white cases to explore the interaction of age, race and
stage. This subset accounted for approximately 86% of the breast cancer population. Adjusted
logistic regressions were run with age, race and stage as predictors of triple negative breast
cancer diagnosis. Interaction effects of age and stage by race were explored. Stage and race were
statistically significant moderators of the relationship between age and diagnoses of triple
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negative breast cancer. As age increased the odds of triple negative diagnosis decreased,
however those diagnosed at late stage had higher odds of triple negative breast cancer compared
to those diagnosed in early stage. Additionally, non-Hispanic black women consistently had
twice the probability of triple negative diagnosis. This study shows that there is significant
burden of disease in triple negative breast cancer for women of color, specifically non-Hispanic
black women, and younger women. Additional studies need to be conducted to determine what
may be driving these disparities between race, age and stage.
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Introduction
Triple negative breast cancer (TNBC) accounts for approximately 15% of all breast
cancer cases, and is associated with aggressive histology, poorer prognosis, shorter survival, and
unresponsiveness to usual hormone therapy (Bauer, Brown, Cress, Parise, & Caggiano, 2007). A
study conducted on a sample of 51,074 women using the California cancer registry found that the
triple negative phenotype was statistically significantly associated with younger age, African
American race/ethnicity, later stage diagnosis, lower SES and shortened survival (Field et al.,
2005). This study is one of a few that include personal SES data. Non-Hispanic black women
also had a significantly earlier age at diagnosis, high grade tumors, and a higher proportion of
triple-negative breast cancers (Chu, Lamar, & Freeman, 2003; Newman, 2005). Chu and
colleagues study had a sample size of 107,612. The focus on TNBC is crucial as there is a lack of
therapeutic options for this specific typology, thus research must shift focus from treatment to
identifying risk factors, albeit environmental or genetic, that exacerbate disparities in breast
cancer diagnosis in order to create and implement more efficacious population-based prevention
strategies.
Although research has established multiple individual-level risk factors associated with
general breast cancer diagnoses, racial disparities still exist, particularly between Non-Hispanic
white and Non-Hispanic black populations. While age-adjusted incidence rates are higher in
Non-Hispanic white women, mortality rates are higher in Non-Hispanic black women. Ageadjusted incidence rates from 2011- 2015 were 128.6 per 100,000 for non-Hispanic white
women and 126.9 per 100,000 for non-Hispanic black women. The age-adjusted mortality rates
from breast cancer in 2011-2015 for Non-Hispanic black women was 28.7 per 100,000 and 20.3
deaths per 100,000 for Non-Hispanic white women (Noone et al., 2018). Research indicates that
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survival in Non-Hispanic black women may be worse due to a higher frequency of adverse
histologic features (Bauer et al., 2007). When examining cases from 2008 to 2014, Non-Hispanic
white women had a higher percentage of localized disease when compared to Non-Hispanic
black women (63% vs 54%), yet the 5-year relative survival rate for Non-Hispanic black women
was lower in terms of localized (99.1% vs 95.4%), regional (86.4% vs 76.6%), and distant stages
(28.1% vs.19.7%) (Noone et al., 2018).
No studies have examined racial disparities in TNBC across the US with the USCS
database, as few have looked beyond the scope of one state. Previous studies have found that age
and race confer a higher risk of breast cancer diagnosis (Howlader et al., 2013). Older age and
has been linked to diagnosis with breast cancer, but this relationship is reversed when we look
further into triple negative breast cancer (Siegel, Miller, & Jemal, 2018). In terms of triple
negative diagnosis, this type occurs more frequently in younger women and in non-Hispanic
black women (Bauer et al., 2007; Dent et al., 2007; Haffty et al., 2006; Harris et al., 2006; Morris
et al., 2007). These findings have been limited due to their small sample sizes, the smallest of
which was 474 cases from a clinical trial (Harris et al., 2006) to the largest of 197,274 cases over
a 10-year period (Morris et al., 2007), thus they are neither spatially representative or
generalizable.
With the use of a population dataset this paper aims to validate previous findings in the
literature, confirming the proportion of breast cancer cases that are triple negative, and the effect
of age, race and stage on diagnosis. The research questions of interest are: Are the underlying
distributions of age, race and stage at diagnosis different for women with TNBC compared to
women with all other types of breast cancer? Do the odds of TNBC diagnosis among women
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with breast cancer differ by race, age or stage at diagnosis, at the individual level? Is there a
difference in odds of diagnosis when we compare late stage to distant stage?
The research hypotheses are as follows: Non-Hispanic black women will have higher
odds of TNBC diagnosis than their non-Hispanic white counterparts in nationally aggregated
data analysis. Younger women will have higher odds of TNBC diagnosis and those diagnosed at
late and distant stage will have higher odds of TNBC diagnosis.
Methods
We examined all breast cancer cases diagnosed during 2010–2014 from the United States
Cancer Statistics (USCS) database, which is a population-based surveillance system of cancer
registries with data representing 99% of the U.S. population (Richardson, Henley, Miller,
Massetti, & Thomas, 2016). Most states participate in the USCS registry data system, but five
did not provide county-level breast cancer data – Illinois, Kansas, Michigan, Minnesota and
Missouri – and four did not code for triple negative data – Connecticut, Iowa, New Mexico, and
Utah. Alaska and Hawaii were excluded from analysis due to missing contextual data.
The dataset was analyzed using SAS Software (SAS 9.4, SAS Institute Inc., Cary, NC).
Triple negative cases were identified using site specific factors 1, 2 and 15. Late stage was
defined as diagnosis at AJCC Stage III and beyond, while distant stage is defined as diagnosis at
AJCC Stage IV. Age groups were defined as less than 40, 40 – 49, 50 -64, 65 – 74, and 75 and
older with age 50 -64 serving as the referent group. There were six race/ethnicity categories in
the study: non-Hispanic white, Hispanic, non-Hispanic black, American Indian/Alaskan Native,
Asian, and Other, with non-Hispanic white serving as the referent category. Descriptive statistics
were calculated for age, race and stage variables in the dataset. Chi-Square tests and the student’s
t-tests were employed to compare differences in the distribution of age, race, and stage in triple
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negative cases versus all other breast cancer cases. Logistic regression was then used to
determine the odds of diagnosis of triple negative breast cancer given breast cancer and its
variation by race, age and stage. Adjusted models were run, and late stage and distant stage were
included in separate models to reduce confounding effects, as the inclusion of both
simultaneously may diminish the effect of each variable. This approach is similar to the Bauer
and colleagues (2007) who conducted the California registry study. A repeated analysis was
conducted on a subset of cases that only included Non-Hispanic white and Non-Hispanic black
women. The interaction of age and stage, stratified by race, was evaluated for this subset.
Results
We identified 1,151,724 breast cancer cases from 2010-2014, with a mean case age of
61.864. Approximately 75% of the cases were non-Hispanic white women, 27.68% were
diagnosed late stage and approximately 5% were diagnosed at distant stage. In this time period,
triple negative cases accounted for 8.4 % of all breast cancer cases (Table 1). Results from ChiSquared tests demonstrate that there is a statistically significant relationship between the
distributions of race, age group, late stage, and distant stage and triple negative breast cancer
diagnosis. The triple negative group had a statistically significant lower mean age, 59.3,
compared to the other breast cancer group, 62.1 (Table 2).
Race, age and late stage were all statistically significant predictors in the unadjusted and
adjusted logistic regression model (Table 3). In unadjusted models, compared to non-Hispanic
white women, Non-Hispanic black, Hispanic and American Indian/Alaskan Native women had
statistically significant higher odds of TNBC diagnosis while Asian and Other women had lower
odds. Non-Hispanic black women had the highest odds of diagnosis (OR=2.27 (95% CI =2.23,
2.31)), while other women had the lowest odds of diagnosis (OR=0.71 (95% CI=0.64, 0.77)),
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compared to Non-Hispanic white women. Out of the age groups, compared to women age 50-64,
women under the age of 40 had the highest odds of TNBC diagnosis, (OR= 1.95(95% CI=1.90,
2.01)) while those age 75 and older had the lowest odds of diagnosis of TNBC (OR= 0.75
(95%CI=0.73, 0.76)). Women diagnosed at late stage were 69% more likely to be diagnosed with
triple negative breast cancer (OR= 1.69 (95%CI=1.68, 1.72)), and women diagnosed at distant
stage were 47% more likely to be diagnosed with TNBC (OR= 1.47 (95%CI=1.43, 1.51)).
In the adjusted model for late stage, only Hispanic women did not have a difference in
odds of TNBC diagnosis compared to non-Hispanic white women. Non-Hispanic black women
had 2.1 times the odds of diagnosis with triple negative breast cancer. The youngest age group
had the highest odds of TNBC diagnosis, while the oldest had the lowest odds. Women age 4049 did not have statistically significantly different odds of diagnosis compared to women age 5064. For those diagnosed at late stage, the odds of triple negative diagnosis were 1.58 times the
odds for those diagnosed earlier than stage three. In the adjusted model for distant stage, the
results were similar. Women age 40-49 had a slightly higher odds of diagnosis with TNBC, 1.09,
while the results remained the same for Hispanic women. Those diagnosed at distant stage had
1.39 times the odds of diagnosis of TNBC.
In the subset analysis, race, age and stage were used to predict TNBC diagnosis among
non-Hispanic black and non-Hispanic white women only. The subset had a size of 973,293
women. All variables in the adjusted model were statistically significant, including the
interaction effect (Table 4). When stratified by race, the predicted probability of diagnosis for
TNBC remained higher for non-Hispanic black women than for non-Hispanic white women
regardless of stage at diagnosis (Figure 1). When we examine probabilities of diagnosis at latestage for non-Hispanic black and non-Hispanic white women, non-Hispanic black women
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consistently had a higher probability of diagnosis. From age 34.8 (2 SD below the mean) to 88.8
(2 SD above the mean), the probability of diagnosis with TNBC for non-Hispanic black women
decreased from 24.4% to 15.4%, while the probability of diagnosis with TNBC for non-Hispanic
white women decreased from 12.4% to 8.2%. The effect of age on stage is slightly greater for
non-Hispanic black women when we compare coefficients (-0.013 v -0.01). Since the magnitude
of the slopes is small, the slope does not appear to drastically change in Figure 1. However, the
slope for non-Hispanic black women is twice as large (-.006) compared to NHW women (-.003).
The probability of TNBC diagnosis for Non-Hispanic white women at the mean age (61.8) and
late stage is 0.10, while for non-Hispanic black women, it is 0.19. The predicted difference in the
log-odds of diagnosis for non-Hispanic black and non-Hispanic white women is 0.374, on
average.
Discussion
In the multi-state subset of the breast cancer population, approximately, 8.5% of cases
were classified as triple negative using site-specific factors. These results find that triple negative
cases account for fewer breast cancer cases (8.5%) than found in previous studies, with smaller
samples focused on a single state, that show estimates between 12 and 15% (Bauer et al., 2007;
Brewster, Chavez-MacGregor, & Brown, 2014; Gretchen, Burke, & Anderson, 2010; Lund et al.,
2008; Parise, Bauer, & Caggiano, 2010; Stark et al., 2010; Trivers et al., 2009). The distribution
of race was different for the triple-negative cases compared to all other breast cancer cases
(p<.0001). Non-Hispanic black women accounted for 10.9% of the other breast cancer cases, but
21.4% of the triple negative cases, while non-Hispanic white women only accounted for 65.7%
of triple negative cases. In Bauer and colleagues study (2007), non-Hispanic black women
accounted 4.4% of other breast cancer cases and 10% of triple negative cases.
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In the present study, age group distributions were statistically significantly different
between other breast cancer and triple negative breast cancer cases (p<.0001). The youngest age
group, less than 40, accounted for 3.8% of other breast cancer cases, and 7.7% of triple negative
cases. In the most comparable registry study (Bauer, 2007), this age group accounted for more
breast (5.7%) and triple negative breast cancer cases (12.2%). The proportion of those diagnosed
at late-stage and distant stage was statistically significantly higher in the triple negative group
compared to the other breast cancer cases. Late stage diagnosis occurred in 37.9% of triple
negative cases, and distant stage diagnosis occurred in 6.6% of triple negative cases. This finding
is contrary to the Bauer study that found that late stage cases of triple negative breast cancer
account for approximately 15% of the cases and distant stage accounted for 4%. We found
evidence of different distributions in age, race and stage at diagnosis compared to previous
studies. These stark differences demonstrate the importance of national population-based studies.
Overall, this descriptive analysis confirms disparities previously found in the literature
and shows that there are significant burdens among women of color, specifically non-Hispanic
black women, younger women, and women diagnosed at a later stage when it comes to triplenegative breast cancer diagnosis. This study found that those burdens are higher among these
groups than previously estimated, potentially due to the use of a more comprehensive population.
These differences were confirmed in the logistic regression analyses. In both adjusted and
unadjusted models, non-Hispanic black women had significantly higher odds of triple negative
diagnosis compared to non-Hispanic white women. The youngest age group also had
significantly higher odds of triple negative diagnosis. Women diagnosed at late and distant stage
had significantly higher odds of triple negative diagnosis. The subset analysis of just nonHispanic black and non-Hispanic white women shows that disparities persist between these two

38

RACIAL AND GEOSPATIAL DISPARITIES IN TRIPLE NEGATIVE BREAST CANCER
groups. In our study, we found that non-Hispanic black women have twice the probability of
diagnosis with triple negative breast cancer, when controlling for age and stage at diagnosis. The
effect of age and stage at diagnosis differed by race group. Younger age conferred higher odds of
diagnosis for both Non-Hispanic black and Non-Hispanic white women, however there is a
larger gap between the probabilities of diagnosis by stage status for non-Hispanic black women.
Given the large sample size and geospatial coverage of the data, these results are
somewhat different and also more generalizable than previous studies. The database needs to be
monitored for a shift in policy and data quality that would allow for the addition of states not
currently included in the analysis. Considering these results, it is important to consider what
additional factors may influence individual level variations in diagnosis. Further exploration into
additional individual and environmental characteristics is necessary to identify what may be
driving these disparities in diagnosis. Due to the aggressive nature of triple-negative breast
cancer, and lack of therapeutic options, it is important to know which groups confer a higher risk
to better provide intervention.
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Tables
Table 1. Descriptive Statistics of Study Population, n=1151724
Variable

N

Race
NHW
862205
Hispanic
95507
NHB
135389
AI/AN
5504
Asian
44424
Other
8695
Age
Age Groups, mean 1151724
<40
47329
40-49
179715
50-64
433798
65-74
275982
75+
214900
Late Stage
Yes
310588
No
811633
Distant
Yes
54073
No
1068148
*Missing
29503
TNBC
Yes
96749
No
1054975

Percent
74.86
8.29
11.76
0.48
3.86
0.75
61.84
4.11
15.6
37.67
23.96
18.66
27.68
72.32
4.82
95.18
2.6
8.4
91.6
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Table 2. Differences in Frequencies of Age, Race, and Stage for Other Breast Cancers and
Triple Negative Breast Cancer
Other BC n=1054975
TNBC n=96749
Test for Difference
Variable
N
Percent
N
Percent
statistic
df
p
2
Race
χ =9851.15
5
<.0001
NHW
798626
75.70
63579
65.72
Hispanic
87069
8.25
8438
8.72
NHB
114663
10.87
20726
21.42
AI/AN
5002
0.47
502
0.52
Asian
41382
3.92
3042
3.14
Other
8233
0.78
462
0.48
Age Groups
χ2=5051.62
4
<.0001
<40
39855
3.78
7474
7.73
40-49
162650
15.42
17065
17.64
50-64
395805
37.52
37993
39.27
65-74
256176
24.28
19806
20.47
75+
200489
19.00
14411
14.90
Mean Age*
62.07
59.28
t=59.86
113867 <.0001
2
Late Stage
χ =7182.29
2
<.0001
Yes
273929
25.97
36659
37.89
No
752341
71.31
59292
61.28
Distant
χ 2=2311.43
2
<.0001
Yes
47661
4.52
6412
6.63
No
978609
92.76
89539
92.55
Missing**
28705
2.72
798
0.82
*Satterthwaite T-test used to compare mean age differences (F=1.08, p<.0001 test for equal
variance). Percent is the mean age for each group.
**This represents the number of cases that were missing stage data.
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Table 3. Association between TNBC diagnosis and Race/Ethnicity, Age and Stage at
Diagnosis
Unadjusted
Variable

Odds
Ratio

95% C.I.

NHW
Hispanic
NHB
AI/AN
Asian
Other

REF
1.217
2.271
1.261
0.923
0.705

<40
40-49
50-64
65-74
75+

1.954
1.093
REF
0.805
0.749

p
value*

1.189, 1.247
2.233, 2.309
1.15, 1.382
0.889, 0.959
0.642, 0.774

0.001
<.0001
0.0174
<.0001
<.0001

1.902, 2.007
1.072, 1.114

<.0001
<.0001

0.791, 0.82
0.734, 0.764

<.0001
<.0001

Yes
No

1.698 1.675, 1.722
REF

<.0001

Yes
No

1.47 1.431, 1.511
REF

<.0001

Adjusted - Late Stage
Odds
p
95% C.I.
Ratio
value*
Race
REF
1.106 1.08, 1.134
2.111 2.075, 2.148
1.188 1.083, 1.305
0.851 0.819, 0.885
0.714 0.646, 0.788
Age Groups
1.759 1.711, 1.808
1.066 1.046, 1.087
REF
0.848 0.833, 0.864
0.816 0.8, 0.833
Late Stage
1.58 1.558, 1.602
REF
Distant

Adjusted - Distant Stage
Odds
p
95% C.I.
Ratio
value*
REF
1.13
2.159
1.213
0.847
0.7

0.3624
<.0001
0.035
<.0001
<.0001
<.0001
0.1083

1.103, 1.158
2.122, 2.196
1.105, 1.332
0.816, 0.88
0.634, 0.772

0.0633
<.0001
0.014
<.0001
<.0001

1.835, 1.939
1.065, 1.106

<.0001
0.0152

0.817, 0.847
0.792, 0.824

<.0001
<.0001

1.388 1.351, 1.426
REF

<.0001

1.886
1.085
REF
0.832
0.808

<.0001
<.0001
<.0001 -

Table 4. Adjusted Logistic Regression Results for Non-Hispanic black/Non-Hispanic white
Subset Analysis, n=973293
Adjusted Model
Variable
Intercept
NHW
NHB
Age
Stage
Age*Stage

p
value*
0.017 <.0001

Est.

S.E.

-1.365
REF
0.374
-0.011
0.136
0.002

0.004
0.000
0.017
0.000

<.0001
<.0001
<.0001
<.0001

Stratified Results
Non-Hispanic white,
Non-Hispanic black,
n=841450
n=131843
p
p
Est.
S.E.
Est.
S.E.
value*
value*
-1.785
<.0001
-0.845
<.0001
-0.010 0.000 <.0001
0.139 0.020 <.0001
0.002 0.000 <.0001

-0.013
0.085
0.003

0.987 <.0001
1.089
0.013
1.003 <.0001
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Figure 1. Interaction Effects of Stage at Diagnosis on Age at Diagnosis by Race
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Abstract
The literature amply demonstrates that disparities exist between age, race and stage of
diagnosis in triple negative breast cancers, however few studies have addressed how the social
environment impacts diagnosis. Evaluation of geospatial patterns reflecting disparities is a
crucial part of cancer research. This ecological study evaluates geographic disparities using
1,151,724 cases of breast cancer from 2010-2014 in 2430 counties across 39 states. The data are
aggregated to the county-level using FIPS codes recorded at the time of diagnosis. County-level
spatial cluster analysis, which is descriptive and spatial regression, which is confirmatory in
ecological modeling at the county level, were employed to analyze geographic patterns of crude
breast cancer and triple negative breast cancer rates and their contextual predictors. County level
contextual factors were drawn from several public-use sources.
Crude rates were defined as the total number of cases from 2010-2014 per 100,000
women. Evidence of spatial autocorrelation in both breast and triple negative breast cancer rates
was found and multiple clusters coincided with one another. The geospatial patterns of crude
breast cancer and triple negative breast cancer rates were distinct from one another, with most
high rate clusters for the former in the North and Northeastern United States, and in the South,
for the latter. We identified where the two types of clusters converged, and 159 counties had both
high breast and triple negative breast cancer rates, while 97 counties had low breast cancer rates
but high triple negative breast cancer rates. In the final spatial error regression model for breast
cancer rates, all residential segregation and socioeconomic variables were statistically significant
predictors. In the final spatial lag + error model for triple negative breast cancer, only the
isolation indices and the diversity index were statistically significant. Both models found that
residential segregation played a role in the outcomes. Future studies need to account for spatial
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dependence when looking at geographic data, such as that provided by the USCS database, and
further explore additional contextual and compositional variables that may contribute to the
variation in county-level breast cancer rates.
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Introduction
Geographic disparities in the diagnosis of breast cancer has been established in the
literature for several years (Carvalho, Bacchi, Pincerato, Van de Rijn, & Bacchi, 2014; Henley,
King, German, Richardson, & Plescia, 2010; Kerner, Andrews, Zauber, & Struening, 1988;
Mobley, Kuo, Scott, Rutherford, & Bose, 2017; Mobley & Kuo, 2015; Scott, Mobley, &
Il’yasova, 2017; Siegel, Miller, & Jemal, 2018; Tian, Wilson, & Zhan, 2011). Kerner and
colleagues (1988) called for the use of spatial analysis to inform prevention strategy and policy
implementation. Since then, a few studies have utilized spatial analysis in the evaluation of
breast cancer (BC) outcomes overall, and none have evaluated the triple- negative subtype
(TNBC) (Kuo, Mobley, & Anselin, 2011; Mobley, Kuo, Watson, & Gordon Brown, 2012;
Sheehan et al., 2004; Wang, McLafferty, Escamilla, & Luo, 2008). Additionally, no such studies
focused on the United States have utilized Anselin’s Local Moran’s I (LISA) statistics in the
analysis (Anselin, 1995). While other methods look for epicenters in a global pattern, the LISA
methodology accounts for local spatial instabilities in overall patterns of global spatial
association. This methodology is considered more reliable for inference in both the absence and
presence of spatial autocorrelation, allowing for the identification of concentrations of both high
and low values, and spatial outliers. Examining the spatial distribution of this aggressive TNBC
typology at the county level provides insight at policy-actionable geographic levels.
Besides comparing the geospatial distribution, it is important to examine underlying
community characteristics. This information can provide insight on the mechanisms by which
TNBC may be occurring more in certain communities compared to others. Previous studies have
compared the distribution of community characteristics between high and low cluster centers,
which is basically a descriptive approach (Mobley, Finkelstein, Khavjou, & Will, 2004; Scott et
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al., 2017). This study aims to delve further by predicting breast cancer and triple negative breast
cancer rates through spatial regression techniques covering the entire geography of the sample,
thereby understanding which variables may have the largest effect on these county level rates.
This ecological study focuses on the association of residential segregation, education and
income inequality on triple-negative diagnosis rates in counties. Residential segregation is
represented by one measure on evenness, the diversity index, and two measures of exposure, the
isolation indices. The isolation indices used in the study focused on the distribution of the nonHispanic black and non-Hispanic white population (Charles, 2003; Massey & Denton, 1988).
Education data was drawn from the United States Department of Agriculture Rural Atlas which
derives estimates from the United States Census Bureau’s American Community Survey. This
variable represented the percent of the population with a four-year college degree or higher. For
income inequality, the Gini index of income inequality and the poverty rate were used. The Gini
index represents the income distribution of a county’s residents and is one of the widely used
measures in the literature on income inequality and health (Chen & Crawford, 2012). A higher
Gini index implies a higher level of area income inequality (Fan, Wen, & Kowaleski-Jones,
2016). It is important to include the various dimensions spatial socioeconomic polarization and
segregation to manage different aspects that might be confounding if omitted, as few studies
have explored the joint impact of spatial economic and racial polarization on population health
(Feldman, Waterman, Coull, & Krieger, 2015; Krieger, Singh, & Waterman, 2016). This study is
driven by ecosocial theory of disease distribution and the hypothesis that women with social and
economic privilege are most likely to have ER+ tumors (Krieger, Singh, & Waterman, 2016).
The research questions are as follows: Is there evidence of geospatial disparities in both
breast cancer and triple negative breast cancer diagnosis across the United States? Do these
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clusters coincide? Can residential segregation and socioeconomic conditions predict triplenegative diagnosis? The research hypotheses are: There will be evidence of observed spatial
patterns (clustering) of higher-than-average and lower-than-average TNBC rates across the
United States. TNBC county rates will be associated with indicators of community disadvantage.
Methods
We examined all breast cancer cases diagnosed during 2010–2014 from the United States
Cancer Statistics (USCS) database, which is a population-based surveillance system of cancer
registries with data representing 99% of the U.S. population (Richardson et al, 2016). Most states
participate in the USCS registry data system, but five did not provide county-level breast cancer
data – Illinois, Kansas, Michigan, Minnesota and Missouri – and four did not code for triple
negative data – Connecticut, Iowa, New Mexico, and Utah. Alaska and Hawaii were excluded
from analysis due to missing contextual data. Community characteristics will be represented
using data from the Spatial Impact Factor Database (Mobley, 2015). The database is
supplemented by additional data from the United States Department of Agriculture and
Pennsylvania State University (Bureau of Health Workforce, 2017; Rupasingha, Goetz, &
Freshwater, 2006).
Independent variables included in the study were non-Hispanic black and non-Hispanic
white isolation indices, Theil’s diversity index, the Gini index of income disparity, poverty, and
educational attainment. Non-Hispanic black and non-Hispanic white isolation indices are
measures of exposure that indicate the probability the specified race group will encounter
another person from their race group within the areal unit (Massey & Denton, 1988). A value of
1 indicates a perfectly racially isolated county for the respective race. Theil’s Diversity index is a
multi-group measure that reflects the level of diversity within the county. This county level
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variable is based on tract-level racial composition. Counties where tracts all have the same
composition (all individuals in a population are associated with the same racial group) have a
low diversity index while counties where different races or ethnicities are separated into cultural
enclaves among the tracts will have high indices (White, 1986). A value of 0 for the diversity
index indicates no diversity in the population while a value of 1 indicates maximum diversity,
where individuals are evenly distributed among two or more mutually exclusive groups
(Roberto, 2015).
The Gini coefficient is the most commonly used indicator of income inequality, and its
use here allows for comparisons with other income inequality studies (Farley, 2006; JonesSmith, Gordon-Larsen, Siddiqi, & Popkin, 2011). The Gini index reflects the degree to which
income is equally shared within a county and is one of the widely used measures in the literature
on income inequality and health (Chen & Crawford, 2012). An index value of 0 represents a
perfectly equal distribution of income while an index value of 1 represents a perfectly unequal
distribution of income. Poverty was represented as the proportion of the population in poverty as
defined by the U.S. Census. Educational attainment was defined as the percent of the population
age 25 and older with a graduate or professional degree (Evenden, Harper, Brailsford, &
Harindra, 2006).
The dataset was combined using the county FIPS code and summary statistics were
computed using SAS Software (SAS 9.4, SAS Institute Inc., Cary, NC). Triple negative cases
were identified using site specific factors 1, 2 and 15. Crude BC rates were defined as the total
number of BC cases from 2010-2014 per 100,000 persons, and crude TNBC rates were defined
as the total number of TNBC cases from 2010-2014 per 100,000 persons. A shapefile was
created and following the approach in Mobley et al (2004) and Schieb et al (2013), the Global
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(Moran’s I) and Local Indicators of Spatial Association (LISA) spatial clustering tests were
performed using GeoDa software (Anselin, Bera, Florax, & Yoon, 1996; Anselin, Syabri, &
Kho, 2006). The Queen Contiguity matrix was used for spatial weights. This type of matrix
defines neighbors as counties that share borders or vertices. Results were mapped in QGIS (free,
open source GIS software). The global Moran’s I test determines if there is global clustering in
the pattern of TNBC rates but cannot identify the location of the clusters, thus we use the LISA
test to identify the local clusters.
The LISA statistic is computed using conditional permutation, or bootstrapping, that
holds the value fixed for the county of interest and randomly permutes the remaining values to
obtain a reference distribution. The observed value is then compared to the distribution to
determine extremity of the value. Thus, LISA statistics are relative to the observations of the
variable of interest and clusters are determined significant at the p < 0.05 level. This was
repeated for each county to 99999 permutations and counties are then classified as either nonsignificant or as falling into four categories, relative to the mean (Anselin, 1995). There are four
types of spatial clusters identified using the LISA statistic: high-high (higher than average rates
adjacent to higher than average rates), low-low, high-low, low-high. Positive spatial
autocorrelation (cluster) in BC and TNBC rates among counties is represented by both high-high
and low-low clusters, while negative spatial autocorrelation (outlier) is represented by high-low
and low-high clusters (Anselin et al., 1995). Clusters are identified when the observation is more
similar to its neighbors as summarized by the spatial lag (weighted average of the neighboring
values) (Anselin, 2004). For spatial clusters, the cores and neighbors are of interest, while for
spatial outliers, the cores are the actual locations of interest (Anselin, 2004).
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Descriptive maps were created to assess the distribution of BC and TNBC rates across the
country (Figures 1 and 2). Additionally, the results of the LISA analyses were mapped. These
maps show the center of the cluster in color (i.e., red for high-high), while the actual extent of the
cluster includes the center and its surrounding neighbors as defined by the queen weights matrix
(Figure 3 and 4). The neighbors are properly included in the cluster, shown here as a grey buffer
zone around the center. Co-location maps are presented, that demonstrates where BC and TNBC
clusters and centers occur concurrently and diverge (Figures 5 and 6). Descriptive statistics were
calculated for the outcome variable, BC and TNBC incidence rates, and the contextual variables
of interest (Table 1)
Due to evidence of strong spatial autocorrelation in the spatial cluster analyses, spatial
regression techniques were employed to estimate the association with county level contextual
factors and both breast cancer rates and triple negative breast cancer rates from 2010-2014
(Tables 3 and 4). Independent variables were assessed for multicollinearity prior to inclusion in
the models. In Geoda, we ran a classic spatial regression – a replication of ordinary least squares
(OLS) regression with spatial diagnostics, specifically, evaluating the Moran’s I statistic and
Lagrange Multipliers (LM) for both lag and error utilizing a queen contiguity matrix for both
breast and triple negative breast cancer rates. OLS must meet certain assumptions: the random
error terms follow a normal distribution, are independent and have a constant variance. Given the
Moran’s I results, the assumption of independence is violated by spatial dependence in the data.
The model specification for OLS (in matrix notation) is as follows:
𝑦 = X𝛽 + 𝜀

𝜀~𝑁(0, 𝜎 2 I)
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where y is the dependent variable with N rows, X is a matrix with observation on K independent
variables, β is a vector with K regression coefficients, ε is the random error term, σ2 is the error
variance and I is an identity matrix of dimension N by N (Chasco, 2013).
In both models, spatial diagnostics show that the Moran’s I of the residuals were
statistically significant, the errors were not normally distributed and were heteroscedastic. The
error model was appropriate for the breast cancer model. For the spatial error model, we utilized
the General Method of Moments (robust to non-normality) estimation with Kelejian & Prucha
(KP) Heteroscedastic-consistent errors. This method allows for robust estimation with
endogenous explanatory variables in the presence of both spatial heteroscedasticity and
autocorrelation (Table 3) (Chasco, 2013; Kelejian & Prucha, 2010). It outputs the coefficient
lambda (λ), which is interpreted as a nuisance parameter. The model specifications with a spatial
autoregressive error term is:
𝑦 = X𝛽 + u 𝑓𝑜𝑟 u = 𝜆W𝑢 + 𝜀
where the additional parameters beyond OLS are defined as W𝑢 is the spatial lag of the errors, λ
is the nuisance parameter and ε is the error with a mean of 0 and variance matrix σ2 (Chasco,
2013).
The lag process was appropriate for the triple negative breast cancer model. For the
spatial lag model, we utilized the General Method of Moments estimation with White variance to
accommodate the heteroscedasticity (Chasco, 2013; White, 1980). This model outputs the
coefficient rho (ρ), which is interpreted as a measure of the extent of spatial spillovers. The
spatial lag model specification with the spatial lagged dependent variable is:
𝑦 = 𝜌𝑊𝑦 + 𝑋𝛽 + 𝜀
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where Wy as a N by 1 vector of spatial lags for the dependent variable, ρ is the spatial
autoregressive coefficient and ε is a N by 1 vector of normally distributed random error terms,
with mean 0 and homoscedastic variances σ2 (Chasco, 2013). The Anselin-Kelejian test for
spatial dependence was statistically significant for the lag model on TNBC rates, indicating
evidence of spatial autocorrelation that was still unaccounted for (Anselin & Kelejian, 1997;
Anselin & Rey, 1991). We then employed a combined spatial lag and error model using the
General Method of Moments estimation with KP Heteroscedastic errors (Table 4). The model
specification for the joint spatial lag and spatial error model is as follow:
𝑦 = 𝜌𝑊𝑦 + 𝑋𝛽 + 𝑢 𝑓𝑜𝑟 𝑢 = 𝜆𝑊𝑢 + 𝜀
where the additional parameters beyond OLS are defined as Wy as a N by 1 vector of spatial lags
for the dependent variable, ρ and λ are the spatial autoregressive coefficients, and ε is the error
term (Chasco, 2013). The inclusion of Wy allows us to assess the significance of the explanatory
variables while controlling for spatial dependence.
Results
From the participating registries in the USCS database, there were 2430 counties in 39
states included in the analysis. The average county-level breast cancer rate was 86.1 cases per
100,000 (SD = 20.9) while the average county-level triple negative breast cancer rates was 7.7
cases per 100,000 (SD = 4.2). There was a large range of values for each of the outcomes, as
demonstrated by Figures 1 and 2. Breast cancer incidence rates ranged from 7.1 to 241.0 cases
per 100,000 while triple negative breast cancer incidence rates ranged from 0 to 30.8 cases per
100,000. The Moran’s I statistic for both BC (I = 0.29) and TNBC (I = 0.22) rates was positive
and statistically significant indicating evidence of clustering or positive spatial autocorrelation.
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There were 231 positive and 264 negative spatial cluster centers found for breast cancer
rates. There were 107 spatial outliers (Figure 3). There were 175 positive and 226 negative
spatial cluster centers identified for triple negative breast cancer rates. There were 117 spatial
outliers (Figure 4). There were 28 cluster centers that coincided for both high BC and high
TNBC rates and 104 cluster centers for both low BC and TNBC rates. There were 5 centers each
that diverged, five that were low BC and high TNBC, and five that were high BC and low TNBC
(Figure 5). When we include the entire clusters, rather than just the centers, there were 159
counties that were High BC-High TNBC, 324 counties that were Low BC-Low TNBC, 97
counties that were Low BC-High TNBC and 54 counties that were High BC- Low TNBC
(Figure 6).
All contextual variables were statistically significant predictors of breast cancer rates in
the breast cancer spatial error model. The nuisance parameter, lambda=0.45, reflects the effects
of omitted county variables that are similar across the county observations. In the spatial lag
model for triple negative rates, only the isolation variables were statistically significant
predictors. The spatial autoregressive parameter, rho=0.59, allows us to assess the significance of
the independent variables after spatial dependence is controlled for. This parameter reflects the
effects of a weighted sum of the values of the dependent variable at other locations (Anselin &
Rey, 1991). The significance of the Anselin-Kelejian test indicates that the spatial
autocorrelation effect is not completely captured by this model. Both spatial parameters were
statistically significant in the final lag + error model. In this model, all residential segregation
variables were statistically significant predictors.
Discussion
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This study found distinct geospatial patterns in crude breast cancer and triple negative
breast cancer incidence rates at the county level. High breast cancer rates were found mainly in
the northern United States (US), while high triple negative breast cancer rates were found more
in the southern US. This may be related to the geographic distribution of race across the United
States. The South and Southeast has the largest concentration of Non-Hispanic black persons
among all regions in the United States. Given the higher odds of diagnosis among non-Hispanic
black women, we could expect a spike in crude rates by region, due to distinct demographic
differences by region. These geospatial patterns were confirmed by the LISA cluster analysis.
The vast majority of High-High clusters for breast cancer rates were found along the Northern
region of the eastern seaboard, as well as across the entire northern United States, with a cluster
in Northeast California and in Central Florida. The majority of New England and Virginia are a
part of High-High clusters. On the contrary, Texas, Nevada and much of the Southeast and South
are a part of the Low-Low clusters for this outcome. Out of 2430 counties, 1434 (59.0%) were
included in a spatial breast cancer cluster.
The LISA Cluster map for crude triple negative breast cancer rates showed a distinctly
different geographic pattern. Results were similar for states like Nevada and Texas, but the
Eastern part of the United States essentially flips in pattern. Almost no counties from New
England are located within a cluster, with the exception of a small cluster in eastern New York.
Virginia, North Carolina, South Carolina, Georgia, Alabama, and Mississippi comprised most of
the High-High clusters, with a few clusters located in the Dakotas, Idaho, and Montana. There
were less counties in a spatial cluster for triple negative breast cancer rates, n=1225 (50.4%). It is
important that future studies explore the dynamics behind spatial outliers, particularly ‘Low-
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High’ counties, to determine mechanisms as to why those counties are faring better than their
neighbors.
Of note, there are 97 counties that have Low BC rates and High TNBC rates (Figure 6).
These clusters were located on the border of Idaho and Montana, Arkansas, Louisiana,
Mississippi, Alabama, Georgia, Florida, Virginia, West Virginia, Nebraska and North Dakota.
As evident by Figures 5 and 6, it is imperative to consider the extent of the full cluster rather than
just cluster centers. We potentially miss important information by solely focusing on the cluster
centers. Future studies should examine predictors of county status and evaluate whether there or
demographic, social, or physical environment differences that distinguish counties in the cluster
category from other counties.
In this study, we examined the associations of social environment factors with breast and
triple negative breast cancer rates. Spatial regression was performed to help assess which factors
had the largest effect estimates. Two income related variables, the Gini Index and poverty rate,
had the largest associations with the breast cancer rate. We would expect a perfectly unequal
county, in regard to the Gini index, to have a 75.6 more BC cases per 100,000 compared to a
perfectly equal county, on average. Every 10% increase in poverty corresponds to 6.9 cases per
100,000 decrease in the breast cancer rate, on average. The residential segregation measures for
isolation had positive associations while the diversity index, a measure of spatial evenness, had a
negative association on the breast cancer rate. The diversity index measures how evenly racial
groups are distributed across the county, regardless of the size of each group (Iceland, 2004). The
higher the value, the more diverse the county. Compared to a perfectly isolated county (where all
tracts have the same composition), we would expect a county with maximum diversity to have
28.1 less BC cases per 100,000 on average. A perfectly segregated non-Hispanic black county is
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associated with a 31.8 increase in BC cases per 100,000 compared to a perfectly integrated
county, while a perfectly segregated non-Hispanic white county is associated with a 47.5
increase in BC cases per 100,000, on average. Non-Hispanic white isolation has a larger effect
on breast cancer rates than non-Hispanic black isolation, but integration (diversity index)
considering all racial units corresponds with decreased breast cancer rates. Finally, county-level
higher education had a substantially small effect on the outcome. For every 1% increase in the
population that has at least a college education, we expect the breast cancer rate to increase by
0.15, on average.
Several of these relationships changed for triple negative breast cancer rates. The
isolation indices and diversity index were the largest and only significant predictors of triple
negative breast cancer rates and income-related variables were no longer significant. A perfectly
segregated non-Hispanic Black county is associated with a 4.6 increase in TNBC cases per
100,000 compared to a perfectly integrated county, while a perfectly segregated non-Hispanic
White county is associated with a 2.2 increase in TNBC cases per 100,000, on average. The
diversity index was negatively associated with the outcome. A perfectly diverse county, with
multiple racial groups distributed among tracts within the county, is expected to have 2.8 less
TNBC cases per 100,000 than a perfectly isolated county, on average. The average influence of
county observations by their neighboring observations is represented by rho = 0.634, while the
nuisance parameter = -0.539.
When using spatial data, it is important to consider spatial dependencies in analysis.
Observations are correlated with others that are spatially proximate, violating the assumption of
independence and resulting in spill-over of information. Failing to account for spatial
dependencies may obscure effects that are indeed present given the data and can impart
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misspecification bias. In this case, spatial diagnostics predicate the use of a spatial error model
for breast cancer rates and a spatial lag + error model for triple-negative breast cancer rates. In
the breast cancer model, if spatial autocorrelation is ignored, the estimators may be unbiased yet
inefficient. Consequentially, inference based on the variance would be biased (Anselin & Rey,
1991). The spatial error model is the correct specification when neighbors react similarly due to a
common underlying phenomenon. The spatial lag or autoregressive model is the correct
specification for a diffusion phenomenon among activities of adjacent neighbors. In the triple
negative model, if spatial autocorrelation is ignored, then the estimators may be biased, along
with the misspecification issues drawn from a spatial error process.
Consequently, given the ecological nature of the study, we cannot infer individual level
behavior from the aggregate rates. Inclusion of individual level variables along with county level
variables may allow us to account for more variation in the data. Additionally, the use of crude
rates limits the interpretation of this analysis as crude rates may be a poor measure of underlying
risk and can spuriously identify outliers in counties with very small populations (Anselin,
Sridharan, & Gholston, 2007). The literature has also demonstrated that TNBC is associated with
age. Appropriate population denominators were not available in the dataset to create age-specific
rates in order to directly adjust the crude rates.
Overall, this study demonstrates that spatial dependencies exist when we examine both
outcomes at an aggregate geographic level. To our knowledge, no previous studies have
examined geospatial clustering of breast and triple negative breast cancer, their co-locations, or
conducted spatial regression to evaluate context. It is imperative that we continue to explore
what is causing these spatial processes to better develop prevention and intervention methods.
Given the ecological nature of the study, it is important to make inferences based around context.
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Characteristics of the counties that had both low breast and triple negative breast cancer rate
could inform policy as to what is working to protect the women in these communities. An
evaluation of differences between those counties and counties where both outcomes are high, or
breast cancer is low and triple negative is high can further elucidate factors that may be driving
these geographic disparities.
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Figure 1. Descriptive Map of 2010-2014 overall breast cancer rates defined by quartile breaks

Figure 2. Descriptive Map of 2010-2014 triple-negative breast cancer rates defined by quartile breaks
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Figure 3. LISA Cluster Map of 2010-2014 overall breast cancer rates

Figure 4. LISA Cluster Map of 2010-2014 triple-negative breast cancer rates
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Figure 5. Coincident LISA Clusters Centers 2010-2014 for BC and TNBC rates

Figure 6. Coincident LISA Clusters 2010-2014 for BC and TNBC rates
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Table 1. Descriptive Statistics for County Level Variables
Variable
Variable Description
R_crude_BC Crude breast cancer rate (cases per 100,000
females)
R_crude_TN Crude triple negative breast cancer rate (cases
per 100,000 females)
Iblack10
Isolation Index: probability that non-Hispanic
black persons will meet other non-Hispanic
black persons within defined area, 2010
Iwhite10
Isolation Index: probability that non-Hispanic
white persons will meet other non-Hispanic
white persons within defined area, 2010
Divr10
Diversity Index (Theil Index): measures the
even-ness or uneven-ness of the spatial
distribution of population subgroups in tracts
within areas (counties), 2010
G25UP1014 percent of population aged 25+ years with a
graduate or professional degree, 2010-2014
GINI_10
GINI index of income disparity, 2010
xpov10
estimated proportion of people of all ages in
poverty for income year, 2010

Mean

Std Dev

Minimum Maximum

86.0783

20.9117

7.080

240.964

7.7351

4.1726

0

30.769

0.26251

0.20741

0

0.8647

0.73452

0.15163

0.03154

1

0.1981

0.0916

0

0.69685

29.56426 10.65997

2.63158

75.09149

0.45547

0.0348

0.3321

0.5985

0.14062

0.05214

0.03408

0.53492
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Table 2. Results of Fitting Multiple Regression Models for Predictors of Breast Cancer Rates (n=2430)
Model 2 – Spatial Error Model
Model 1 - OLS in GeoDaSpace
(HET)
Est.
S.E.
p value
Est.
S.E.
p value
Intercept
23.212
6.123
0.000
21.472
6.715
0.001
Divr10
-23.890
5.330
<.0001
-28.127
7.100
<.0001
G25UP1014
0.258
0.052
<.0001
0.152
0.064
<.0001
GINI_10
67.729
14.413
<.0001
75.592
16.511
<.0001
Iblack10
32.221
2.718
<.0001
31.799
3.425
<.0001
Iwhite10
45.941
3.002
<.0001
47.541
3.797
<.0001
xpov10
-68.027
9.023
<.0001
-69.229 10.909
<.0001
lambda
0.448
0.027
<.0001
R2
0.1947
0.1922
Model F-test
97.61
(df1, df2) (7, 2423)
Spatial Dependence Diagnostics
MI/DF
Est.
p value
Jarque-Bera Test
2
2195.771 <.0001
Bruesch-Pagan test
6
55.82
<.0001
Moran's I (error)
0.223
18.096
<.0001
Lagrange Multiplier (lag)
1
296.865 <.0001
Robust LM (lag)
1
2.836
0.0922
Lagrange Multiplier (error)
1
320.585 <.0001
Robust LM (error)
1
26.556
<.0001
Est= Parameter Estimate; S.E.= standard error; lambda = Nuisance Parameter; HET = KP
Heteroscedastic Errors; Multicollinearity Condition Number = 53.816
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Table 3. Results of Fitting Multiple Regression Models for Predictors of Triple Negative Breast Cancer Rates (n=2430)
Model 1 –
Model 2 Model 3 OLS in GeoDaSpace
Spatial Lag Model
Spatial Lag +Error (HET)
Est.
S.E.
p value
Est.
S.E.
p value
Est.
S.E.
p value
Intercept
5.066
1.277
<.0001
1.681 1.532
0.273
1.778 1.327
0.180
Divr10
-5.882
1.112
<.0001 -2.968 1.593
0.062
-2.808 1.340
0.036
G25UP1014
-0.009
0.011
0.405
-0.017 0.010
0.080
-0.007 0.009
0.395
GINI_10
-4.645
3.007
0.123
0.355 3.692
0.923
-1.720 3.313
0.604
Iblack10
9.975
0.567
<.0001
5.189 1.101 <.0001
4.553 1.130 <.0001
Iwhite10
4.928
0.626
<.0001
2.159 0.865
0.013
2.173 0.780
0.005
xpov10
0.299
1.882
0.874
-2.954 2.258
0.191
-1.061 1.977
0.592
rho
0.586 0.113 <.0001
0.634 0.109 <.0001
lambda
-0.539 0.090 <.0001
R2
0.1196
0.1751
0.1723
Model F-test
54.85
(df1, df2) (7, 2423)
Spatial Dependence Diagnostics
MI/DF
Est.
p value MI/DF Est.
p value
Jarque-Bera Test
2
1251.63 <.0001
Bruesch-Pagan test
6
163.652 <.0001
Moran's I (error)
0.1214
9.918
<.0001
Lagrange Multiplier (lag)
1
108.189 <.0001
Robust LM (lag)
1
13.881
0.0002
Lagrange Multiplier (error)
1
95.219
<.0001
Robust LM (error)
1
0.912
0.3397
Anselin-Kelejian Test
1
9.983
.0016
Est= Parameter Estimate; S.E.= standard error; rho = Autoregressive Parameter; HET = KP Heteroscedastic Errors;
Multicollinearity Condition Number = 53.816
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Abstract
While multiple individual level factors have been identified to play a role in the etiology
of breast cancer and triple negative breast cancer, few studies have used mixed modeling
techniques to explore the role that additional levels of predictors may play in triple-negative
breast cancer. Since disparities persist even when known factors are accounted for, the scope of
research must be expanded to examine factors that contribute to disparate outcomes at an
ecological level. Mixed modeling can perhaps better account for the spatial heterogeneity in
these cases. Random intercept mixed models can account for different effects across areas, yet it
assumes higher levels are independent, thus is limited in terms of handling spatial dependence. In
this study, we explored the odds of triple negative diagnosis, given breast cancer diagnosis, at the
individual level controlling for individual, county and state level variables. When controlling for
county and state level predictors, disparities by age, race and stage persisted. Non-Hispanic black
women had consistently had twice the odds of diagnosis with TNBC, women age 40 and under
had 1.7 times the odds of diagnosis and women diagnosed at late stage had 1.5 times the odds of
diagnosis. County-level residential segregation and educational attainment variables were
significant predictors of triple negative diagnosis, while no state level policy variables were
statistically significant predictors, after controlling statistically for random state intercepts which
account for other omitted state variables. Residential isolation proved to be disadvantageous to
diagnosis, while residential diversity and area educational attainment were protective. Future
studies should continue to explore various environmental factors, physical and social, that
contribute the variation in disparate rates of diagnosis.
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Introduction
The use of the mixed models is gaining popularity in studies that investigate area-level
risk factors (e.g. socioeconomic conditions, residential segregation, social capital, access to
primary care healthcare providers, and state insurance mandates) related to individual breast
cancer outcomes (Gomez et al., 2015). Mixed models can provide greater insights and explain
substantially more of the variation in the observed TNBC outcomes. Individual risk factors are
consistently studied and identified, and neighborhood deprivation has been associated with poor
breast cancer diagnosis, treatment and survival (Downing, Prakash, Gilthorpe, Mikeljevic, &
Forman, 2007; Akinyemiju et al., 2013; Tannenbaum, Koru-Sengul, Miao, & Byrne, 2013;
Markossian, Hines, & Bayakly, 2014; Thomson, Hole, Twelves, Brewster, & Black, 2001;
Sprague et al., 2011). No studies, to our knowledge, have examined multi-level effects,
specifically of community deprivation, on triple negative breast cancer (TNBC) diagnosis. The
inclusion of county and state level variables in multilevel modeling can potentially explain
additional variation in TNBC diagnosis at the individual level. With this enhanced knowledge,
and effective dissemination and translation of it, policies and interventions can be designed and
targeted to address the barriers and gaps that contribute to the observed TNBC outcomes. Model
building for multilevel analysis will allow us to explore how these various levels of predictors
contribute to diagnosis of TNBC among BC patients.
The literature using atomistic modeling of single-level individual data has provided
several facts. One study found that having low self-reported education was associated with
subtypes of estrogen receptor negative and progesterone receptor negative breast cancers
(Trivers et al., 2009). Additionally, women in their study with triple negative tumors were more
often of lower self-reported SES. Low socioeconomic status has been linked to decreased rates
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of screening, greater probability for late-stage diagnosis, receipt on inadequate and disparate
treatment and higher mortality from breast cancer (Bigby & Holmes, 2005; Gerend & Pai, 2008).
Regardless of race, poverty is associated with poorer breast cancer outcomes (Gerend & Pai,
2008). Women who reside in disadvantaged communities may be required to travel longer
distances with longer wait times to utilize screening and treatment facilities. These factors can
cause a major hindrance in regular physician visits (Mandelblatt, Andrews, Kao, Wallace, &
Kerner, 2010; Mandelblatt, Andrews, Kerner, Zauber, & Burnett, 1991; Mandelblatt, Yabroff, &
Kerner, 1999; Vernon, Vogel, Halabi, & Bondy, 1993).
Key factors in health care utilization involve accessibility. There is evidence to suggest
that when nurse practitioners are allowed to practice and prescribe medicine independently, that
adults utilize the healthcare system more frequently (Kuo, Loresto, Rounds, & Goodwin, 2013;
Mobley et al., 2017; Stange, 2014). Underinsurance takes into account an insured adult’s
reported out-of-pocket costs over the course of a year, not including premiums and deductibles.
A person is defined as someone whose (a) out-of-pocket costs, excluding premiums, over the
prior 12 months are equal to 10 percent or more of household income; (b) out-of-pocket costs,
excluding premiums, are equal to 5 percent or more of household income if income is under 200
percent of the federal poverty level ($22,980 for an individual and $47,100 for a family of four);
or (c) deductible is 5 percent or more of household income (Collins, Rasmussen, Beutel, & Doty,
2015). From 2010 to 2014, twenty-three percent of insured adults were underinsured. Uninsured
and underinsured women are less likely to undergo screening, more likely to receive a late stage
diagnosis and less likely to survive (Bradley, Given, & Roberts, 2002; Buseman, Byers, Finch, &
Jacobellis, 2002; Gerend & Pai, 2008; Gordon, Rundall, & Parker, 1998; Hsia et al., 2000;
Roetzheim et al., 1999). Low-income women have mammography screening rates that are lower
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than higher income women (Peek & Han, 2004). Additionally, women with lower education
have lower mammography screening rates (Kerner et al., 2001).
Few studies have explored the role of social environmental risk factors in triple negative
breast cancer diagnosis and, of those, most are analyzed at a single level. Chu and colleagues
found that race or ethnicity had no effect on recurrence or survival among TNBC patients, when
controlling for ZIP code-based income, but did not use hierarchical techniques (Chu, Henderson,
Ampil, & Li, 2012). Parise and Caggiano (2017) created an SES index with Census data and did
not find an increase in odds of TNBC compared to ER-/PR-/HER2+ due to low SES for all
races/ethnicities using logistic regression. Bauer and colleagues use a similar SES index as above
in logistic regression and found that TNBC affects younger, non-Hispanic black and Hispanic
women in areas of low SES (Bauer et al, 2007).
This paper explores the relationship between age, race and stage at diagnosis and triplenegative diagnosis among women with breast cancer. As noted in the literature above, disparities
based on age, race, and stage have been widely published, but additional contributions to the
literature can be made by exploring and controlling for area-level contextual effects (Howlader et
al., 2013). In this paper, we include additional social environmental risk factors that may better
inform both policy and clinical practice. We include area-level factors including residential
segregation, income inequality, educational attainment and social capital (at the county-level)
and health insurance rates, mammography screening, and scope of practice regulation policy (at
the state level). The social environment variables in the socioecological model on the cancer
continuum drives the theory behind inclusion of variables in this study (Figure 1) (Gomez et al,
2015). We may still find that there are certain disparities that persist with the addition of these
variables. The use of multilevel modeling allows you to control for these contextual factors and
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examine whether the aforementioned person-level relationships remain robust after inclusion of
additional levels of context. We are also able to examine whether there is any substantial impact
from area context by looking at the level-2 and level-3 results.
The research questions are as follows: What is the predicted probability of triple negative
breast cancer diagnosis, given breast cancer diagnosis, among females in an average county in
the United States? What community variables are strong predictors of triple negative breast
cancer diagnosis among breast cancer cases? When we control for patient, county and state
characteristics, what is the relationship between patient race and odds of TNBC diagnosis, given
breast cancer diagnosis? The research hypotheses are: TNBC diagnosis will vary for females
across counties and counties within states and will be associated with several factors reflecting
community disadvantage. We anticipate that the odds of triple negative breast cancer diagnosis
will remain higher for Non-Hispanic black women compared to Non-Hispanic white women,
even when controlling for county and state level characteristics. Multilevel analysis will explain
the variation in diagnosis within and between racial groups using person, county and state level
predictors.
Methods
We examined all breast cancer cases diagnosed during 2010–2014 from the United States
Cancer Statistics (USCS) database, which is a population-based surveillance system of cancer
registries with data representing 99% of the U.S. population (Richardson et al, 2016). Most states
participate in the USCS registry data system, but five did not provide county-level breast cancer
data – Illinois, Kansas, Michigan, Minnesota and Missouri – and four did not code for triple
negative data – Connecticut, Iowa, New Mexico, and Utah. Alaska and Hawaii were excluded
from analysis due to missing contextual data and ill-defined counties, leaving 39 states in the
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analysis. Community characteristics will be represented using data from the Spatial Impact
Factor Database (Mobley, 2015). The database was supplemented by additional data from the
Area Health Resource File and Pennsylvania State University (Bureau of Health Workforce,
2017; Rupasingha, Goetz, & Freshwater, 2006).
Person-Level Factors
Late stage was defined as diagnosis at stage 3 and beyond. Age groups were defined as
less than 40, 40 – 49, 50 -64, 65 – 74, and 75 and older with age 50 -64 serving as the referent
group. There were six race categories in the study: Non-Hispanic white, Hispanic, Non-Hispanic
black, American Indian/Alaskan Native, Asian, and Other, with Non-Hispanic white serving as
the referent category.
County-level factors
County level data included in the model were non-Hispanic black and non-Hispanic
white isolation indices, Theil’s diversity index, Gini index of income disparity, poverty, social
capital and educational attainment. Non-Hispanic black and non-Hispanic white isolation indices
are measures of exposure that indicate the probability the specified race group will encounter
another person from their race group within the areal unit (county) (Massey & Denton, 1988). A
value of 1 indicates a perfectly racially isolated county for the respective race. Theil’s Diversity
index is a multi-group measure that reflects the level of diversity within the county. Counties
where tracts all have the same composition (all individuals in a population are associated with
the same racial group) have a low diversity index while counties where different races or
ethnicities are separated into cultural enclaves among the tracts will have high indices (Mobley,
2015; White, 1986). A value of 0 for the diversity index indicates no diversity in the population
while a value of 1 indicates maximum diversity, where individuals are evenly distributed among

82

RACIAL AND GEOSPATIAL DISPARITIES IN TRIPLE NEGATIVE BREAST CANCER
two or more mutually exclusive groups (Roberto, 2015). The Gini coefficient is the most
commonly used indicator of income inequality, and its use here allows for comparisons with
other income inequality studies (Farley, 2006; Jones-Smith, Gordon-Larsen, Siddiqi, & Popkin,
2011). The GINI Index of family income inequality reflects the degree to which income is
equally distributed between families within a county. A coefficient of 0 represents a perfectly
equal society where every family has the same income, while a coefficient of 1 represents a
perfectly unequal society with a great divergence between the richest and poorest families.
Poverty was represented as the proportion of the population in poverty as defined by the U.S.
Census. Social capital was a normalized index developed using the number of the following
establishments in each county: (a) civic organizations; (b) bowling centers; (c) golf clubs; (d)
fitness centers; (e) sports organizations; (f) religious organizations; (g) political organizations;
(h) labor organizations; (i) business organizations; and (j) professional organizations, along with
the percentage of voters in presidential elections, county-level Census response rate, and the
number of tax-exempt non-profit organizations (Alesina & La Ferrara, 2000; Knack, 2002;
Rupasingha et al., 2006). Education was further defined from US Census data as the percent of
the population age 25 and older with a graduate or professional degree (Evenden, Harper,
Brailsford, & Harindra, 2006).
State-level factors
State level variables were nurse practitioner (NP) autonomy laws, percent underinsured,
and mammography screening rates. Data on NP regulations was provided by the National
Conference of State Legislatures (NCSL). Underinsurance data are presented as percent of adults
who were underinsured in 2012 (Collins et al., 2015). Mammography screening rates were
obtained from the Centers for Disease Control and Prevention Behavioral Risk Factor
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Surveillance System. These values represent the percent of women age 40 and over who had a
mammogram in 2010.
The dataset was combined and summary statistics were computed using SAS Software
(SAS 9.4, SAS Institute Inc., Cary, NC). Triple-negative diagnosis was coded using site specific
factors 1, 2 and 15. County and state level data were merged using the FIPS codes. Univariate
and bivariate relationships were examined in SAS 9.4. Due to the hierarchical structure of the
data, with cases nested in counties, nested in states, we employed mixed modeling techniques.
The outcome of interest was triple negative diagnosis (Yes/No) at the individual. In all the mixed
models, we specified a binary distribution with a logit link. Utilization of the logit response
function is appropriate when the response probability is small because the logistic distribution
has greater tail probability than the normal distribution (Gibbons & Hedeker, 1997). Due to the
size of the dataset and limitations in time, we optimized PROC GLIMMIX to ensure
convergence in the models. We suppressed the print options and random effects solutions. The
denominator degrees of freedom method employed was between-within, which utilizes less
computing resources than the default containment method. Newton-Raphson Ridging option was
employed with max iterations set to 50, as this option is appropriate in binary distributions
(Kiernan, Tao, & Gibbs, 2012). Laplacian approximation was not employed in this study due to
non-convergence of models, rather residual subject-specific pseudo-likelihood was used. This
does not allow for model comparison using -2 Log Likelihood values and model output did not
include any other model fit statistics such as the AIC or BIC.
An intercept-only mixed model, with a test for random intercepts at level 2 and 3, was
run and the intraclass correlation was calculated (Snijders & Bosker, 2011). The ICC explains
the percent of the total variance accounted for at various levels. The ICC for state level was
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(Raman and Hedeker, 2005). To explore and control for

contextual county-level effects, we continued to add on to the intercept-only model. Further
model building included a model with level-1 predictors followed by a model with level-2
predictors, followed by three separate models, one for each level-3 predictor. We allowed for
random effects at the county and state level. A small ICC indicated that the variance in the
observed response stems more from individual differences within groups. However, omitted
contextual effects could conceivably impart bias on the included person-level effects. We
converted the estimates to population case-only odds ratios. We refer to this odds ratio with this
nomenclature because the population contains only cases on breast cancer, thus it is not a true
case-control. This population case-only odds ratio approach has been used in cancer studies
where the authors are examining genes and mutations that lead to cancer (Rosenbaum, 2004).
Results
This study included 1,102,113 individuals, 2430 counties, and 39 states. Descriptive
statistics for the independent variables are presented in Table 1. The intraclass correlation was
0.008 for states, 0.019 for counties and states, and 0.427 for counties. This indicates that the
likeness of cases in the same states is 0.81%, the likeness of cases in the same counties in the
same states is 1.89%, and the likeness of counties in the same states is 42.7%. The individual
predicted probability of diagnosis in an average county within an average state is 8.7%, derived
from the log odds of TNBC diagnosis in the intercept only model (Table 2).
The results of model-building are presented in Table 2. Age, race and stage were
significant predictors of TNBC diagnosis, given BC diagnosis, in all 6 models. In terms of race,
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the referent group was non-Hispanic white women in the case only population. Non-Hispanic
black women had twice the odds of diagnosis even when controlling for county and state level
covariates. Hispanic and American Indian/Alaskan Native women also had higher odds of
diagnosis. Asian and Other women had lower odds of diagnosis. Those age less than 40 had the
highest odds of diagnosis compared to the referent group of 50 -64 years. This age group was 1.7
times more likely to be diagnosed with TNBC given BC diagnosis. Age 40-49 had slightly
higher odds, while both age groups above 65 had lower odds of diagnosis. Those diagnosed at
late stage had 1.6 times the odds of diagnosis with TNBC compared to those diagnosed prior to
stage III.
Isolation indices, the diversity index, and education were statistically significant
predictors of TNBC diagnosis given BC diagnosis. Compared to a perfectly integrated county, an
individual in a perfectly segregated county has approximately 1.3 times the predicted odds of
diagnosis with TNBC in regard to non-Hispanic black isolation, and approximately 1.2 times the
predicted odds of diagnosis in regard to non-Hispanic white isolation. Compared to a perfectly
isolated county (where all tracts have the same composition), individuals in a county with
maximum diversity (multi-group) have approximately 0.7 times the predicted odds of diagnosis
with TNBC. For every one unit increase in percent of the population that is educated beyond
college, the predicted odds of diagnosis with TNBC is decreased by 0.9. No state level variables
were statistically significant predictors of triple negative diagnosis.
Discussion
Even with small variance components, it is still imperative to explore social and policy
factors that may have implications in individual TNBC diagnosis. In an average county and state,
the individual level predicted probability of TNBC diagnosis was 8.7%, given breast cancer
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diagnosis. Even when controlling for county and state level factors, non-Hispanic black women
experienced higher odds of diagnosis of TNBC, followed by Hispanic and American
Indian/Alaskan Native women. Asian women and Other women had lower odds of diagnosis.
Younger age and late stage at diagnosis also conferred higher odds of diagnosis.
At the county level, residential segregation is associated with TNBC diagnosis. NonHispanic black and non-Hispanic white isolation confers higher odds of diagnosis, regardless of
individual race, controlling for all other factors. However, the diversity index confers lower odds
of diagnosis. The diversity index is a multi-group measure of spatial evenness that quantifies
how evenly racial groups are distributed across the tracts within each county. A value of 0 for the
diversity index indicates no diversity, where all tracts have the same composition, while a value
of 1 indicates maximum diversity, where all racial or ethnic groups are evenly distributed but
may be segregated into cultural enclaves among tracts (Roberto, 2015). Thus, diversity within
the county confers lower odds of diagnosis at the individual level. Residential segregation has
been a widely studied phenomenon with no consensus on whether it is detrimental or beneficial
to health. The aim is to determine whether it creates an adverse environment or provides social
support(Acevedo-Garcia, Lochner, Osypuk, & Subramanian, 2003; Boustan, 2013; Bower et al.,
2015; Charles, 2003; Collins, 1999; Collins & Williams, 1999; Dai, 2010; Dinwiddie, Gaskin,
Chan, Norrington, & McCleary, 2013; Haas et al., 2008a, 2008b; Hao et al., 2011; Hayanga,
Zeliadt, & Backhus, 2013; Kershaw, Albrecht, & Carnethon, 2013; Mobley, Kuo, Scott,
Rutherford, & Bose, 2017; Mobley, Scott, Rutherford, & Kuo, 2016; Williams & Collins, 2001).
For these particular outcomes, we found that area-level residential segregation, specifically,
isolation, was detrimental for health, and that diversity within counties provided better outcomes.
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Area-level higher education conferred lower odds of individual diagnosis while income
inequality and poverty had non-significant effects.
No state level variables were significant predictors of individual level TNBC diagnosis.
However, we expected nurse practitioner laws to have an impact on diagnosis as the literature
demonstrates improvements in the provision of preventive services to patients when a nurse or
NP offered screening directly to the patients, bypassing the physician (Beach et al, 2006). There
is also favorable evidence to support the use of bypassing providers of minority patients to offer
standardized services (Beach et al, 2006). Another study on Medicare beneficiaries found that
NPs are also more likely to serve younger populations, females, and minorities, as well as dually
eligible Medicare and Medicaid. Importantly, they were more likely to practice in primary care
shortage areas (DesRoches, Gaudet, Perloff, Donelan, Iezzoni & Buerhaus, 2013). We may not
have found a significant effect because the variable is analyzed at three levels. Nurse practitioner
autonomy could potentially increase access for communities most likely to be affected by TNBC
diagnosis, specifically younger female populations. Future studies where the variable is
dichotomized as full autonomy versus reduced or restricted practice may elucidate the role that
state-level nurse practitioner autonomy plays in individual diagnosis. From 1987 – 2000, 42
stated adopted screening mandates requiring private insurers within the state to include
mammography benefits in insurance plans (Bitler and Carpenter, 2011). Given the screening
mandate, we would expect states to have a higher utilization of mammography screening which
in turn would affect outcomes. However, there isn’t much literature to show that generous
insurance coverage will increase screening utilization and millions of Americans still remain unor underinsured (Bitler and Carpenter, 2011). Overall, we expected access to care, represented
by the state variables, to lower the odds of diagnosis with TNBC, rather than finding a null
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effect. However, it is important to note that even with control of these state-level policy
variables, disparities still existed and individual and county level effects were not attenuated.
It is important to note that penalized quasi-likelihood estimates of random components in
generalized mixed models with dichotomous outcomes have previously been found to have a
downward bias when there are few observations per group (Capanu, Gönen, & Begg, 2013;
Goldstein & Rasbash, 1996; Raudenbush, Yang, & Yosef, 2000; Rodriguez & Goldman, 1995).
Given the size of the dataset, we were not concerned with small cell sizes, but acknowledge this
as a potential source of bias. Future studies should consider the use of a numerical integration
method such as Laplacian or Adaptive Quadrature. It is important to consider the role the social
environment plays in individual level diagnosis. Further exploration of macro-level factors is
necessary to truly evaluate disparities in triple negative diagnosis. Individual level disparities
were not eliminated with the addition of county and state level variables. We found that even
when we control for individual age and stage, county residential segregation, education, income
inequality levels, and state level policy variables, Non-Hispanic black women still had the
highest odds of TNBC diagnosis compared to non-Hispanic white women, followed by Hispanic
and AI/AN women. The addition of SES variables at the individual level as well as cross-level
interactions may provide different insights into what is driving disparities. An exploration of the
physical context (e.g. environmental contaminants) may elucidate further what may be driving
the observed TNBC disparities, as well as policy variables.
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Figure 1. Socioecological model on the Cancer Continuum (Gomez et al., 2015)
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Table 1. Descriptive Statistics for County and State Level Variables
Variable
Iblack10

Variable Description
Mean
Std Dev
Isolation Index: probability that non0.26251
0.20741
Hispanic black persons will meet other
non-Hispanic black persons within
defined area, 2010
Iwhite10
Isolation Index: probability that non0.73452
0.15163
Hispanic white persons will meet other
non-Hispanic white persons within
defined area, 2010
Divr10
Diversity Index (Theil Index): measures
0.1981
0.0916
the even-ness or uneven-ness of the
spatial distribution of population
subgroups in tracts within areas
(counties). 2010
G25UP1014 percent of population aged 25+ years
29.56426
10.65997
with a graduate or professional degree,
2010-2014
GINI_10
GINI index of income disparity, 2010
0.45547
0.0348
sk09
Social capital index created by
-0.70851
0.83828
Pennsylvania State University, 2009
xpov10
estimated proportion of people of all
0.14062
0.05214
ages in poverty for income year 2010
UNDER12 percent of the population that is
10.37237
5.20211
underserved by primary care providers,
2012 (Kaiser)
XMAM10
percent of the population that received
78.57239
3.71165
mammograms in 2010 (BRFSS)
frequencies for Categorical Variables
NP2012 = 0 NP2012 = 1
NP2012
Whether state allowed NPs autonomy
(County)
(County)
to diagnose, treat, and prescribe without
1575
455
physician oversight. 0: Full autonomy;
(State)
(State)
1: Reduced Practice; 2: Restricted
18
7
Practice

Minimum
0

Maximum
0.8647

0.03154

1

0

0.69685

2.63158

75.09149

0.3321
-3.92523

0.5985
17.4405

0.03408

0.53492

0.32525

31.50783

68.3

87.5

NP2012 = 2
(County)
400
(State)
14
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Table 2. Mixed Modeling Results for Three-Level Binary Outcome Models to Predict Triple-Negative Diagnosis among Females with Breast Cancer
Model 1
Intercept Only
Estimate SE
Intercept
Race
Non-Hispanic white
Non-Hispanic black
Hispanic
AI/AN
Asian
Other
Age Groups
50-64
<40
40-49
65-74
75+
Late Stage
No
Yes

-2.3546

0.02789

REF

REF

REF

Model 2
Level 1
OR

95% CI

Model 3
Level 1 + 2
OR
95% CI
Level 1

Model 4
Level 1 + 2 + NP Law
OR
95% CI

-2.5285

0.02036

REF
2.068
1.186
1.116
0.897
0.754

2.029, 2.107
1.155, 1.218
1.014, 1.229
0.862, 0.934
0.682, 0.833

REF
2.06
1.189
1.114
0.903
0.756

2.02, 2.101
1.158, 1.222
1.011, 1.227
0.868, 0.94
0.684, 0.835

REF
2.06
1.189
1.113
0.903
0.756

REF
1.769
1.076
0.845
0.819

1.72, 1.819
1.055, 1.097
0.83, 0.861
0.802, 0.836

REF
1.773
1.078
0.844
0.818

1.724, 1.823
1.057, 1.099
0.829, 0.86
0.801, 0.835
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Previous studies in the literature have focused on individual level risk factors, especially
with the triple negative subtype. The literature found that triple negative cases account for 10%
to 15% of all breast cancer cases, while this study found that approximately 8% of cases were
triple negative using site specific factors 1, 2 and 15. Several (13) states were excluded from
analysis due to lack of either data as a whole or triple negative classification data. Also, the study
began with 2010 data because prior to that time, registries inconsistently coded TNBC. There is
a need for more comprehensive and reliable data collection from registries, in order to truly
capture each case. These studies in this dissertation found that race, age and stage at diagnosis
play a significant role, regardless of additional control variables.
The three manuscripts presented in this dissertation focused on identifying individual and
community level factors in triple-negative diagnosis and geographic distribution and disparities
in breast cancer and triple negative breast cancer rates. The overarching goal of this study was to
evaluate racial and geographic disparities in triple-negative breast cancer (TNBC) diagnoses by
race or ethnicity both within regions and across regions and advance the field of populationbased research in breast cancer disparities through innovative statistical techniques. Goals of
each of the three individual manuscripts were, respectively: (1) to establish the odds of diagnosis
of triple negative breast cancer among breast cancer cases by age, race, and stage at diagnosis,
(2) evaluate the geospatial distribution of county-level breast and triple negative breast cancer
rates and their associations with community level characteristics (socioeconomic conditions and,
residential segregation), and (3) examine multilevel effects of county and state level variables on
individual level triple negative diagnosis among breast cancer cases.
The literature demonstrates that TNBC accounts for 12-15% of all breast cancers, but no
studies have been conducted at a national level with as rich of data as the USCS. This study

104

RACIAL AND GEOSPATIAL DISPARITIES IN TRIPLE NEGATIVE BREAST CANCER
identified 96,749 TNBC cases among 1,151,724 BC cases in the United States across 5 years,
2010 – 2014. The first study aimed to validate previous findings in the literature. No studies have
been conducted on TNBC at the national level with as comprehensive of a dataset, and this is the
first of its kind to explore differences in person-level factors at such a large scale. We utilized
traditional epidemiologic methods to evaluate individual level differences, but these methods can
confound race and place. The second study built upon the first to describe geospatial patterns in
the disease at the county-level using exploratory spatial data analysis and examine associations
with contextual factors using confirmatory spatial data analysis. There are no studies in the
literature that examine TNBC and BC outcomes and clustering patterns across the United States,
nor use spatial regression to account for spatial dependence in the outcomes. We know that there
are both micro- and macro-social processes that can impact health and health outcomes. In the
third study, we aim to account for multi-level influences on individual TNBC diagnosis, to
address the fallacies of single-level research.
The first study found that triple negative breast cancer cases account for fewer breast
cancer cases than previously described in the literature. This study found that TNBC accounted
for 8.5% of cases, whereas previous literature estimates that TNBC accounts for 12-15%. The
study found that, consistent with the literature, in both unadjusted and adjusted analyses, race,
age and stage were significant predictors of triple negative diagnosis. However, this study found
that the burdens among women of color, specifically non-Hispanic black and Hispanic women,
younger women, and women diagnosed at later stage are actually higher than previously
estimated. We found evidence of different distribution of age, race and stage at diagnosis
compared to previous studies. Non-Hispanic black and Hispanic women had higher odds of
triple-negative diagnosis, compared to Non-Hispanic white women. Women under the age of 50
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had higher odds of triple negative diagnosis while women over 64 had lower odds of diagnosis,
compared to women age 50 to 64. Diagnosis at stage III and beyond and stage IV and beyond
also conferred higher odds of diagnosis.
The second study found evidence of significant spatial autocorrelation in both breast
cancer and triple negative breast cancer rates across counties. There were distinct geospatial
patterns of the crude BC and TNBC rates. The concurrence of breast cancer and triple negative
breast cancer clusters demonstrated areas of need where both breast cancer and triple negative
breast cancer incidence rates are higher than average, and where breast cancer rates are lower
than average while triple negative rates are higher than average. Special attention needs to be
paid to counties within these clusters. Spatial regression revealed strong effects for residential
segregation and education, implying that community context may vary across communities along
with their triple negative diagnosis rates. Additional studies examining other social and physical
environmental characteristics need to be employed to further elucidate the association between
environmental factors and triple negative diagnosis.
The third study examines spatial heterogeneity in the likelihood of TNBC diagnosis
through the use of mixed modeling. The significant variance components at the county and state
level suggest that there is correlation among observations at each of these levels. County-level
residential segregation and education variables were found to be significant predictors of triple
negative diagnosis at the individual level. No state level variables were statistically significant,
but inclusion of these variables allow for control for state-level policy. No individual level
effects were attenuated due to the addition of county and state level effects, indicating that robust
estimates of disparities exist even with the control of various contextual variables.
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Overall, the studies show that disparities exist by age, race and stage even when
controlling for spatial heterogeneity and dependence. Controlling for these area-level effects is
important when population data span the country and geographic disparities are a possible
confounder. Several studies have examined whether it is the race or the place that is determining
disparities, and the importance of including these area context variables in population studies that
span the country (Gomez et al., 2015). These three individual level factors - age, race and stage are important to consider in the diagnosis of triple negative breast cancer and targeting of early
intervention.
There were several contextual variables that were associated with breast cancer and triple
negative breast cancer rates. To discover robust disparity estimates at the individual level, it is
necessary to include them in the model for conceptual reasons. Further research should be
conducted to identify other contextual variables of interest that may contribute to variation in
rates. The addition of compositional effects along with the variables currently included as
contextual effects may also reveal different results. As argued by Oakes, to truly know area
contextual effects, one must hold constant statistically compositional effects that could confound
the estimates due to selection bias of individuals into communities (Oakes, 2009). Because the
focus here was on how omitted context might impact individual-level estimates, we used the
model specification described here.
Given the large sample size and spatial coverage of the data, these results are more
generalizable than previous studies. Triple-negative data did not become reliable within the
registries until 2010, and all states still do not include the necessary variables to identify triple
negative cases. The study is dependent upon and limited by the accuracy of the registry data.
There is a need for exploration of many other variables that may play a role such as food
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environment data, since obesity and physical activity have been linked to breast cancer, and
physical environment data. Research needs to continue to explore what other variables that may
be driving disparities, including the physical environment.
Although the study is the largest of its kind, we were unable to include the full scope of
the dataset in the analysis due to data sharing restrictions or lack of information on the TNBC
outcome. Triple negative breast cancer can be identified using three site specific factors, SSF1,
SSF2, SSF15 equal to ‘020’, and several states did not code appropriately. The study included 39
states of the 48 available. However, we were still able to identify over 1 million BC cases in the
5-year span. We found that triple negative cases accounted for far less than previously identified
in the literature. This may be due to the use of a subset of 39 states. Comparisons of findings
with the entire SEER registry, as well as annual evaluations of the data, may further validate
what number may truly represent the prevalence of TNBC cases among BC cases. In the second
study, we utilized crude rates due to lack of appropriate population data within the Research Data
Center to create age-adjusted rates. The geospatial portion of this study needs to be repeated and
validated using age-adjusted rates. The third study did not find any effects on individual level
diagnosis for the state level predictors. We expected nurse practitioner autonomy to have an
impact on diagnosis as the literature demonstrated that NPs often serve low access communities.
We may not have found an effect because the variable was analyzed at three levels. The mixed
modeling could be repeated with the NP variable at 2 levels, either comparing full autonomy to
the remaining two categories or full restriction to the remaining two categories. The social
capital variable was a normalized variable that was not found to be a significant predictor in any
of the mixed models. This creates difficulties in interpretation. In a comparison study of social
capital indices, it was found to be a conceptually valid and robust measure of collective social

108

RACIAL AND GEOSPATIAL DISPARITIES IN TRIPLE NEGATIVE BREAST CANCER
capital (Lee & Kim, 2013). Future studies could consider manipulation of the variable to a more
intuitive measure prior to including it in modeling. Additionally, this study used penalized quasilikelihood estimates which can have a downward bias in generalized mixed models with
dichotomous outcomes and small group cells. Given the size of the dataset, this was not a
concern, but it is acknowledged as a potential source of bias. Future studies should employ
Laplacian or adaptive quadrature methods. Mixed models account for spatial heterogeneity but
not spatial dependence. Future studies should employ spatial mixed modeling techniques as the
capability becomes available.
Repeated trend studies from 2010 forward are necessary to track disparities in triple
negative breast cancer and determine whether improvements towards equity have been made.
Since the study was employed at multiple levels, it can serve to inform policy at both the local
and state level. Given the results of this study, there are additional drivers of disparities that are
currently unaccounted for. Exploration from a theory driven standpoint can further elucidate
these drivers. It is necessary that researchers consider all possible influences on breast cancer
disparities and shift focus from the individual to the community. The geospatial analysis showed
that there exists geospatial disparities. Future studies could examine geospatial disparities for
race-specific or age-specific rates to determine if these patterns persist when the data are
stratified.
Overall, this study adds to the growing literature of triple negative breast cancer
disparities. It found that triple negative breast cancer cases accounted for fewer breast cancer
cases than previously identified in the literature, and that disparities between women based on
race, age, and stage at diagnosis were more pronounced. It found that Non-Hispanic black
women consistently had twice the odds of diagnosis with triple negative given breast cancer
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diagnosis. Women age 40 and under had almost twice the odds of diagnosis and women
diagnosed at stage III and beyond had 1.5 times the odds of diagnosis. The distributions of age,
race and stage at diagnosis were distinctly different from what had been previously identified in
the literature. Additional attention should be paid to other individual level characteristics that
confer a higher risk of diagnosis. It found that residential segregation plays a role in diagnosis as
well. In both the spatial regression and mixed model, the latent variables of isolation indices for
non-Hispanic white and non-Hispanic black persons as well as the diversity index were
consistently statistically significantly associated with TNBC outcomes at the county and
individual level. Residential isolation in non-Hispanic black or non-Hispanic white isolated
counties were associated with an increase in breast cancer or triple negative breast cancer rates,
and increased odds of individual diagnosis with triple negative breast cancer. Diversity within
the counties was associated with a decrease in breast cancer and triple negative breast cancer
rates, and decreased odds of individual diagnosis. County-level higher education was negatively
associated with both breast and triple negative breast cancer rates and conferred lower odds of
triple negative diagnosis. These findings imply there may be additional processes driven by
residential segregation that promulgate the disparity in diagnosis. It is imperative that cancer
research continue to explore the micro- and macro-social processes that impact diagnosis with
TNBC, given its aggressive nature. Treatment development cannot be the only course of action
when tackling such a heterogeneous disease. This study provides a foundation from which
additional studies can move forward from, further exploring individual and contextual factors
that continue to drive disparities in triple negative breast cancer.
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